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 The glycine receptor (GlyR) is a ligand-gated ion channel and a member of the 
cys-loop receptor family.  Like other members of this family, the GlyR is a target for 
many drugs of abuse, including alcohol.  While the effects of alcohol on these receptors 
have been well-characterized, the contribution of each receptor subtype to the overall 
physiological and behavioral effects of alcohol use are unclear.  This is partially due to 
the limited pharmacology of the GlyR, which limits the ability to isolate GlyR function 
within a complex system.  One method for identifying compounds that bind to and 




large number of peptide sequences for affinity at a given target.  We developed a phage 
selection protocol to identify peptides that bind to the GlyR.  These peptides were then 
tested for functional effects at the GlyR using two-electrode voltage clamp physiology.  
We identified several peptides that were able to modulate GlyR function.  Peptide D12-
116 showed specificity for the GlyR over two closely related γ-aminobutyric acid 
(GABA) channels.  In addition, this method is easily adapted for the selection of peptides 
that bind to any cell-expressed target, increasing the utility of phage display in the 
neurobiology field.  Another shortcoming in GlyR pharmacology is the lack of 
modulators with specificity for a single GlyR subtype.  We next adjusted our selection 
protocol to search for peptides that can distinguish between the different Gly R α 
subtypes.  We identified several promising lead peptides that show subtype preference.  
Finally, we found that trifluoroacetic acid (TFA), a common peptide contaminant, also 
modulates GlyR function.  This finding has important implications for both previously 
reported peptide modulators and the pharmacology of several volatile anesthetics, for 
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1.0 | INTRODUCTION 
 
 A multitude of compounds alter the function of the central nervous system (CNS) 
by modulating various enzymes, transporters, and receptors.  Some compounds, like 
benzodiazepines, act with high specificity at a single target (Mihic et al., 1994).  
However, many of these compounds alter the function of several targets simultaneously, 
resulting in a complex mechanism of action.  This complexity makes it difficult to assess 
which of the many biological targets of the compound are important for which aspects of 
the behavioral effects elicited.  One approach for addressing this question is the 
development of compounds that mimic the effect of the compound or specifically block 
the effect of the compound at only one of its biological targets.  These highly specific 
modulators could then be used to determine how changes at individual targets contribute 
to the complex behavioral response elicited by the original compound.  In this thesis, I 
explore one of the methods for identifying novel modulators, phage display, and use it to 
identify modulators for a specific target of a widely used CNS drug, alcohol.   
 
1.1 – Alcohol 
Alcohol, the common term for ethanol, is one of the most commonly used drugs 
of abuse.  With the exception of nicotine addition, alcoholism is the most common 
addictive disorder, due primarily to its high accessibility and the social acceptability of its 




liver and heart disease, ethanol misuse has wider social implications.  According to the 
center for disease control, alcohol is involved in two out of three violent crimes, and 
causes an estimated 75,000 deaths annually.  In spite of centuries of ethanol use and the 
significant social impact of this drug, the mechanism by which ethanol exerts its actions 
in the central nervous system (CNS) remain poorly understood. 
The original mechanism of action proposed for ethanol involved non-specific 
interactions with the constituents of cell membranes, in particular lipids.  This theory was 
based on the observation by Meyer and Overton that the potencies of alcohols and 
general anesthetics were proportional to their partition coefficients between oil and water 
(Franks and Lieb, 1997a).  Short chain alcohols are amphiphilic, and thus localize 
primarily in the head group region of the lipid bilayer.  The inclusion of alcohols in the 
cell membrane disrupts the packing of the lipid components, leading to an increase in 
fluidity, permeability, and lateral mobility (Frischknecht and Frink, 2006).  Chronic 
ethanol administration causes biophysical changes in membranes that result in resistance 
to this lipid-disordering effect (Goldstein and Chin, 1981), and these changes coincide 
with the development of behavioral tolerance.   
However, several aspects of alcohol behavior are inconsistent with this theory.  
First, the degree of lipid disorganization seen at intoxicating concentrations of ethanol is 
very small and is also seen when the temperature is raised by only 1oC.  This temperature 
change has no effect on behavior, suggesting that lipid disorganization alone is not 
sufficient to induce intoxication (Franks, 2006).  In agreement with this, A2C, a 




agents, fails to produce anesthetic-like effects (Buck et al., 1989).  The lipid theory is also 
unable to account for the cut-off effect seen in alcohols.  Increasing the carbon backbone 
chain length of alcohols increases their membrane:buffer partition coefficients; however, 
this is not always correlated with an increase in alcohol potency, and a cut-off is observed 
at which further increases in alcohol potency are not seen, despite increasing chain length 
(Pringle et al., 1981).  In addition, several anesthetic compounds have optical isomers 
that, despite being equally lipid soluble, have significantly different anesthetic potencies 
(Franks and Lieb, 1997b).  The most important shortcoming of this theory is its inability 
to explain how nonspecific changes in the membrane eventually alter the function of 
membrane-associated proteins, even though this is widely accepted to be the ultimate 
result (Franks, 2006).  These inconsistencies led to a search for alternate sights of action 
for alcohols and anesthetics. In the early 1980s, Franks and Lieb (1984) demonstrated 
that clinically relevant concentrations of anesthetics could inhibit the function of the 
cytosolic enzyme firefly luciferase.  As this enzyme is not embedded in the membrane, 
nonspecific membrane effects do not alter its function.  The anesthetic inhibition of 
luciferase function not only showed good correlation with the concentrations used to 
achieve anesthesia in animals, but also demonstrated a cut-off effect, suggesting that the 
anesthetics were interacting with the enzyme at a binding site with fixed dimensions 
(Franks and Lieb, 1985).  This discovery instigated the search for CNS proteins that were 
directly modulated by alcohols and anesthetics at behaviorally relevant concentrations. 
An abundance of electrophysiological and biochemical evidence for the modulation of 




Brunner, 1985; Huidobro-Toro et al., 1987; Gage and Robertson, 1985; Buck et al., 
1989); however, it was unclear if these effects were due to direct interactions with 
channel proteins or indirect effects on lipids.  Conclusive evidence for direct alcohol-
protein interactions was provided by the crystallization of LUSH, an odorant binding 
protein found in Drosophila melanogaster (Kim et al., 1998).  The LUSH protein was 
crystalized in the presence of various alcohols, and the structure showed an ethanol 
molecule stabilized by hydrogen bonds at a binding site with a threonine-serine-threonine 
motif.  This provided direct evidence for alcohols binding at a discrete site on a protein 
(Kruse et al., 2003).  
The evidence for proteins as direct targets for alcohol, such as luciferase, initiated 
the search for alcohol binding sites on CNS proteins.  Motifs similar to the one identified 
in LUSH can be found in several CNS proteins whose functions are modulated by 
alcohols, and mutational studies have identified specific residues on several CNS 
enzymes and channels that mediate the effects of ethanol.  As a full review of this work 
would be quite extensive, the identification of alcohol binding sites will be limited to 
only a few targets and will be discussed in section 1.3.3.  
In the past three decades, a large number of putative ethanol targets have been 
identified, including various enzymes and ion channels.  While the identification of 
possible protein targets for ethanol has been highly successful, the large number of 
targets complicates the efforts to understand the specific mechanism of action for this 
drug.  In addition, most of these targets only show significant modulation in response to 




much lower concentrations (5 – 20 mM).  This suggests that the effects of low 
concentrations of ethanol are either mediated by as of yet unidentified targets, or through 
a combination of small changes in several systems.  Thus, one of the central questions in 
the alcohol research field today is how the modulations of a large number of putative 
protein targets combine to generate the complex behavioral responses seen in response to 
ethanol.   
 
1.2 - Cys-loop Family of Receptors 
Ion channels form the basis of the inter-neuronal communication in the neural 
system, allowing neurons in the CNS to communicate through chemical and electrical 
signals.  As previously mentioned, the function of several families of ion channels is 
modulated by ethanol.  Of these channels, the Cys-loop family of receptors has been 
extensively studied with regards to ethanol effects.  This family consists of two anion-
conduction channels, γ-aminobutyric acid type A and C (GABAA/C) and glycine receptors 
(GlyR), and three cation-conduction channels, serotonin type 3 (5-HT3), nicotinic 
acetylcholine (nACh), and the recently discovered zinc-activated channels (Davies et al., 
2003; Lynch, 2004; Lester et al., 2004).  Ethanol affects almost all of the members of this 
family, and these modulatory effects are consistent with several of the behavioral effects 
of ethanol intoxication (Hyytia and Koob, 1995; Narahashi et al., 1999; Lovinger, 1997).  
For the purposes of this thesis, I will focus my discussion on a single member of this 
family, the glycine receptor (GlyR).  However, I will start with a brief overview of 





1.2.1 – Cys-loop Receptor Structure 
The members of this receptor family are membrane-spanning ion channels that 
are activated by neurotransmitters (ligand-gated) and are responsible for fast excitatory 
and inhibitory transmission.  Agonist binding leads to the opening of an integral ion-
selective channel that allows the passive transport of permeant ions, resulting in either 
depolarization or hyperpolarization of the neuronal membrane (Maksay, 2009).  Cys-loop 
channels have several common characteristics that have been largely elucidated from the 
electron microscopic structure of the Torpedo nicotinic acetylcholine receptor (nAChR) 
and the crystal structure of the ACh binding protein (Brejc et al., 2001; Unwin, 1995).  
The more recent crystallization of several eukaryotic channels (GLIC, ELIC, and GluCl) 
has further enhanced our understanding of how the structure and function of these 
channels are related (Hilf and Dutzler, 2008; Bocquet et al., 2009; Hibbs and Gouaux, 
2011).   
The basic receptor structure is formed by five subunits distributed around a 
central ion-conducting pore.  Each of the five subunits contains four transmembrane 
(TM) domains, with the second domain (TM2) contributing to the formation of the pore 
(Figure 1.1).  The large extracellular N-terminal domain (ECD) contains both the 
neurotransmitter binding site and the characteristic cysteine disulfide bonds that give this 
family of channels their cys-loop structure.  A large intracellular domain (ICD), 
consisting primarily of a loop of amino acids connecting TM3 and TM4, is involved in 













Figure 1.1 – Schematic of a nicotinic acetylcholine receptor 
 
(A) Illustration of a nicotinic acetylcholine receptor subunit showing the extracellular N-terminal ligand 
binding domain, the four transmembrane domains (M1 – M4), and the intracellular loop connecting M3 
and M4.  (B) Five subunits are arranged to form a single receptor.  The intersubunit acetylcholine 
binding sites and the central ion-conducting pore are indicated.  Adapted from Karlin A. (2002). 







1.3 - Glycine Receptor 
Glycine was first proposed to be a neurotransmitter in the spinal cord, where it 
has an inhibitory effect on motoneuron excitability (Davidoff et al., 1967; Werman et al., 
1967).  Glycine, synthesized from serine by serine-hydroxymethyltransferase, is 
packaged into synaptic vesicles and released following an action potential cascade (Daly 
and Aprison, 1974; Legendre, 2001).  The first attempts to clone glycine-activated 
channels yielded two subunits, the 48 kDa α1 subunit and the 58 kDa β subunit (Pfeiffer 
et al., 1982).  Based on the homology of the a1 subunit with the previously cloned 
subunits of the nAChR, the GlyR was classified as a member of the Cys-loop family of 
receptors (Grenningloh et al., 1987b).  
Subsequent homology screens identified two more α subunits (α2 and α3).   A 
fourth a subunit (α4) was identified in mice and chicks, but is only a pseudo-gene in 
humans (Lynch, 2004).  These subunits form pentamers consisting of either five a 
subunits (homomeric receptors) or a mixture of α and β subunits (heteromeric receptors).  
The inclusion of the β subunit causes a significant reduction in single channel 
conductance and changes in channel kinetic behavior compared to homomeric receptors 
(Beato et al., 2004).  While the β subunit cannot form homomeric channels (Bormann et 
al., 1993), it is necessary for interactions with various intracellular components, most 
notably gephryn, which mediates receptor clustering at the synapse (Fritschy et al., 2008).  
Based on electrophysiological measurements, the stoichiometry of heteromeric GlyRs 




tandem constructs suggest that these channels actually consist of 2 α and 3 β subunits 
(Langosch et al., 1988; Grudzinska et al., 2005).  
 
1.3.1 – Activation and Gating of the GlyR 
As with other cys-loop receptors, the GlyR is designed to mediate fast neural 
transmission.  In the absence of neurotransmitter, these channels exist in a closed state 
with extremely low or non-existent spontaneous opening events. In addition to glycine, 
these channels can also be activated by other amino acids, most notably β-alanine and 
taurine.  Glycine is more efficacious than the other ligands (Lynch et al., 1997), which 
are typically thought to act as partial agonists on these channels.  However, the levels of 
taurine in some brain regions have led to speculation that it may act as the primary ligand 
of GlyR in certain areas (Mori et al., 2002; Ericson et al., 2006).  
During channel activation, glycine binds to the ligand-binding site in the ECD.  
The binding site is a pocket-like structure formed by b-sheets connected by flexible loops 
(Brejc et al., 2001).  This site is located between subunits, with three loops from one 
subunit forming the principal binding site (domains A-C) and three β-sheets from an 
adjacent subunit contributing a complimentary binding site (domains E-F).  Thus, each 
homomeric GlyR is thought to have a total of five possible ligand-binding sites.  
However, the binding of only three glycine molecules is sufficient to fully activate these 
channels (Beato et al., 2004).  Based on work done using the ACh binding protein 
(AChBP) structure, glycine is hypothesized to be stabilized within the binding site by 




Dougherty, 2002).  Consistent with this theory, mutations that removed aromatic residues 
from the hypothesized binding pocket altered the sensitivity of GlyR to glycine, taurine, 
and β-alanine.  
When a neurotransmitter binds to a cys-loop receptor, a cascade of movement 
within the channel protein, described as a Brownian conformational wave, carries the 
binding signal to the gate (Grosman et al., 2000).  Unwin (1995) proposed that agonist 
binding initiated a rotation in the binding region that enables contact between the β-
sheets of the ECD and the extracellular linker region that connects TM2 with TM3. The 
movement of this linker region then causes the TM2 segments lining the pore to twist 
away from one another, allowing ions to flow down their concentration gradients 
(Miyazawa et al., 2003).  A ring of positively charged residues within the pore serves as a 
selectivity filter allowing only anions, primarily chloride, to flow through.  The role of 
the remaining two TM segments in channel activation and gating is less clear.  However, 
this region is involved in the modulation of these channels by several second messenger 
systems, including PKC, PKA, PKT, (Lynch, 2004) and Gbg (Yevenes et al., 2003).  In 
addition, mutations in this region have been shown to partially account for the extremely 
reduced taurine responses in α3-containing receptors compared to a1-containing 
receptors, suggesting a possible role for this region in the modulation of the binding 
signal (Chen et al., 2009).  The pore closes when either the ligand dissociates away from 






1.3.2 – Localization and Function of the GlyR 
Original localization experiments using [3H]strychnine, a highly specific GlyR 
competitive antagonist, found high levels of surface-expressed GlyRs in the spinal cord, 
pons, thalamus, and hypothalamus (Zarbin et al., 1981).  Later work with a GlyR α-
subunit antibody reported additional distributions of GlyR in the cerebellum, olfactory 
bulb, and hippocampus (van den Pol and Gorcs, 1988).  GlyRs have also been found in 
several structures of the basal ganglia circuit, a region that is important for motor control 
and mood (Waldvogel et al., 2007).  These receptors are abundantly expressed in the 
retina, where they are thought to play a role in the transition from day to night vision 
(Grunert, 2000; Ivanova et al., 2006).  Recently, GlyR expression has also been reported 
in forebrain regions.  The expression of GlyRs in the basolateral amygdala suggests that 
these receptors might play a role in anxiety disorders (McCool and Botting, 2000).  Of 
particular relevance to this thesis, GlyRs were recently found in the nucleus accumbens 
(NAcc) and the ventral tegmental area (VTA), regions that play important roles in the 
reinforcing effects of drugs of abuse (Jonsson et al., 2009; Ye et al., 2001a).  This 
discovery led to a renewed interest in the GlyR as a modulator of ethanol-related 
behaviors. 
The abundance of these receptors in the spinal cord makes them the dominant 
inhibitory system in the brainstem and spinal cord.  The influx of chloride ions through 
the GlyR channel has an inhibitory effect on neuronal excitability, thus mutations or 
deletions of this channel lead to startle phenotypes (Lewis et al., 1998; Lynch et al., 




disorder characterized by an exaggerated response to unexpected stimuli that is often 
accompanied by temporary muscular rigidity (Rajendra and Schofield, 1995).  This 
disorder is the result of a reduction the magnitude of glycine-gated chloride currents, and 
several mutations throughout the channel have been linked to this disease (Lynch, 2004). 
Traditionally, the α1 subunit was thought to be the most abundant subunit in the 
adult CNS, and thus the majority of GlyR research focused exclusively on this subtype.  
However, the advent of improved localization techniques and subunit-specific antibodies 
have allowed for a more detailed analysis of GlyR subunit expression (Malosio et al., 
1991).  For example, in the adult hippocampus, extrasynaptic α2 and α3 subtypes and 
somatic α3-containing receptors are more abundant than α1/α1β receptors (Aroeira et al., 
2011).  GlyR expression in the amygdala varies by region, with α1β expression 
dominating the basolateral amygdala and α2β and α3β expressed highly in the central 
region (Delaney et al., 2010).  All four subunits (α1-3 and β) are expressed in the NAcc, 
but α2 is the most prevalent (Jonsson et al., 2009).  Although the various a subunits are 
highly homologous in amino acid sequence, these channels differ in their sensitivities to 
ligands and several modulators (Lynch, 2009), suggesting that the differential expression 
of these subunits could serve as a fine-tuning mechanism in GlyR transmission.  For 
example, in the spinal cord, α1β channels are the dominant form, but only the α3-
containing receptors are thought to contribute to the GlyR modulation of inflammatory 






1.3.3 - GlyR and Alcohol 
The enhancing effect of ethanol on glycine-mediated currents was first 
demonstrated in chick spinal neurons (Celentano et al., 1988).  This potentiation was 
subsequently confirmed in brain synaptosomes, isolated neurons, and human GlyRs 
expressed in heterologous systems (Engblom and Akerman, 1991; Aguayo and Pancetti, 
1994; Eggers et al., 2000; Mascia et al., 1996a).  Pharmacologically relevant 
concentrations (50-100 mM) of ethanol cause a persistent, reversible increase in glycine-
mediated currents.  This change is not caused by increases in either presynaptic events or 
GlyR single channel conductance levels, suggesting that ethanol increases the probability 
of GlyR channel opening (Eggers et al., 2000).  
Based on the cutoff effect seen with long-chain alcohols, ethanol was 
hypothesized to bind at a specific site with discrete dimensions (Mascia et al., 1996a).  In 
an attempt to locate this binding site, Mihic et al. (1997) generated chimeric channels 
using segments from the GlyR and GABAC channels.  Unlike other members of the 
GABAA/C family, GABAC receptors are inhibited by ethanol (Mihic and Harris, 1996).  
By combining segments from GlyR and GABAC subunits, the authors were able to 
identify the region between TM2 and TM3 as the area responsible for mediating the 
effects of ethanol and the volatile anesthetic isoflurane.  Two residues within this region, 
S267 and A288, were shown to be critical for the potentiating effects of ethanol on the 
GlyR (Mihic et al., 1997).  The size of the residue at the S267 position is inversely 
correlated with the potentiating effects of ethanol (Ye et al., 1998), suggesting that this 




accessibility experiments, in which individual residues are mutated to cysteines and 
tested for their abilities to crosslink with various thiol reagents, have been used to 
investigate whether binding to these residues is sufficient to modulate channel activity.  
The covalent binding of either propanethiol or propyl methanethiosulfonate (PMTS) to 
the S267C leads to an irreversible enhancement of channel function and blocks further 
enhancement of the channel by alcohols and anesthetics (Mascia et al., 2000).  
In addition to the TM2-TM3 region, residues in the ECD have also been 
suggested to play a role in ethanol modulation.  As previously mentioned, α2 receptors 
show reduced sensitivity to the effects of alcohol.  These differences have been attributed 
to a single amino acid, A52.  Mutation of this residue to a serine results in α1 GlyRs that 
show a reduced sensitivity to ethanol, similar to α2, which has a threonine in this position 
(Mascia et al., 1996b).  PMTS experiments examining the interaction between S267 and 
A52 found that when ethanol bound to A52 alone, it produced an inhibitory effect, while 
binding only to S267 leads to potentiation (Crawford et al., 2008).  This suggests that the 
ethanol modulation of this channel is actually a summation of positive and negative 
allosteric effects. These residues are thought to form a single, large binding site that can 
accommodate several ethanol molecules (Crawford et al., 2007).  The binding of alcohols 
to this pocket is traditionally thought to alter the pocket size, thus stabilizing the open 
state conformation of the channel (Cheng et al., 2008).  However, recent work involving 
single channel recordings shows that the binding of ethanol increases burst duration, 
associated with an antagonization of glycine unbinding, without affecting open 




The exact location of this binding pocket has been the subject of some debate as 
the precise orientation of the contributing residues is unknown.  Early mutagenesis work 
suggested that the binding pocket was located in a water-filled cavity between the TM 
domains of a single subunit (intrasubunit binding) (Mascia et al., 2000; Lobo et al., 2004; 
Bertaccini et al., 2005).  However, modeling studies using the more recent GLIC and 
ELIC structures place this binding pocket at the interface between adjacent subunits 
(intersubunit binding) (Cheng et al., 2008; Murail et al., 2011).  In the absence of a GlyR 
crystal structure, it is difficult to definitively identify the location of this pocket.  
However, the structure of an anesthetic bound to the GLIC channel was recently solved 
(Nury et al., 2011).  Interestingly, this structure includes both an intrasubunit and 
intersubunit water-filled cavity connected by a small linking tunnel.  The size and shape 
of these cavities are hypothesized to change during channel gating, suggesting that both 
cavities could be accessible to alcohols and anesthetics in a state-dependent manner.  This 
is consistent with previous mutagenesis work showing that certain residues important for 
alcohol binding are only accessible in the open state (Lobo et al., 2004).  
   Intracellular mechanisms have also been suggested to modulate the effects of 
ethanol on the GlyR.  The large intracellular loop between TM3 and TM4 is the target of 
phosphorylation by protein kinases A (PKA) and C (PKC) (Song and Huang, 1990; 
Vaello et al., 1994; Ruiz-Gomez et al., 1991).  Phosphorylation by PKC was shown to 
modulate the channel responses to ethanol, but not to glycine (Mascia et al., 1998). G-
proteins also interact with the TM3-TM4 intracellular loop (Zhu and Ye, 2005) and have 




degree of interaction between GlyR and the Gβγ heterodimer alters the potentiation of 
glycine-activated currents by alcohol (Yevenes et al., 2008). The Aguayo group has 
suggested that these interactions are not only important for modulating the effect of 
ethanol on the GlyR, but may in fact be the primary mechanism through which ethanol 
potentiates these channels (Guzman et al., 2009; Yevenes et al., 2010).  These data 
highlight the complexity of the interaction between ethanol and the GlyR. 
Several of the behavioral effects of ethanol are consistent with the idea that this 
drug enhances the inhibitory GlyR current.  A common behavioral measurement of 
intoxication by ethanol is the loss of righting reflex (LORR), characterized by increased 
difficulty in standing upright.  LORR can be reinstated in animals that have recovered 
from ethanol-induced LORR by intracerebroventricular injections of glycine and serine, 
the glycine precursor (Williams et al., 1995), while strychnine, a GlyR antagonist, 
abolished these effects.  Experiments in knock-in mice carrying a point mutation at 
residue S267 in the α1 GlyR subunit further support the hypothesis that GlyRs are 
important for the motor incoordinating and anesthetic effects of ethanol (Findlay et al., 
2002).  These animals showed reduced LORR and motor incoordination following 
ethanol administration.  In addition, they were less sensitive to the anticonvulsant effects 
of ethanol during strychnine-induced seizures.  GlyRs in supraspinal regions are thought 
to play a role in ethanol-induced hypnosis, the loss of consciousness (Ye et al., 2009). 
More recently, GlyR activity in the NAcc and VTA was demonstrated to alter the 
rewarding effects of ethanol.  These brain regions are part of the mesolimbic dopamine 




abuse (Leshner and Koob, 1999; Gatto et al., 1994; Di Chiara and Imperato, 1988).  
Ethanol intake increases GlyR responses in the VTA in adult cells; however, in neonatal 
cells, ethanol decreases GlyR responses, suggesting the possibility that these channels 
may contribute to the development of fetal alcohol syndrome (Ye et al., 2001b).  In adult 
animals, the direct application of glycine into the NAcc causes an increase in 
extracellular dopamine in this area and a concomitant decrease in voluntary ethanol 
intake (Molander et al., 2005), while the application of strychnine produces the opposite 
effect.  Taurine and β-alanine also increase dopamine levels in the NAcc (Ericson et al., 
2006; Ericson et al., 2010). Glycine elevation in the NAcc is thought to result in a 
disinhibition of the GABAA neurons that project to the VTA. This disinhibition leads to 
an increase in acetylcholine output from the VTA, which in turn causes an elevation of 
dopamine levels in the NAcc (Ericson et al., 2003; Soderpalm et al., 2009).  During 
ethanol operant self-administration, elevated levels of taurine in the NAcc were found.  
The magnitude of this increase correlated with the amount of ethanol consumed (Li et al., 
2008).  An increase in the NAcc glycine concentration was also reported.  Interestingly, 
this increase began several minutes prior to the presentation of ethanol, suggesting that 
glycine may be involved in the anticipation of reward. Systemic administration of 
Org25935, a selective inhibitor of the glycine transporter 1 (GlyT1), successfully 
increased the level of glycine and dopamine in the NAcc and decreased ethanol 
consumption (Molander et al., 2007).  This decline in ethanol intake persisted even after 
the reintroduction of ethanol following deprivation, suggesting that the modulation of 




(Vengeliene et al., 2010).  Cumulatively, these data support the hypothesis that the GlyR 
plays an important role in several aspects of alcohol addition, including initiation, 
maintenance, and relapse (Vengeliene et al., 2008). 
Several studies have attempted to delineate the exact role of GlyR in ethanol-
mediated behaviors.  Knock-out and knock-in animal studies have offered several 
insights and helped verify some of the in vitro data. However, as with all studies of this 
type, perturbing the system can lead to significant side effects.  For example, the S267Q 
mutant mouse displayed a strong startle phenotype, making it difficult to compare to 
wild-type behaviors (Findlay et al., 2003).  For the majority of GlyR studies, 
heterozygous animals must be used because the homozygous knock-out or mutation is 
fatal (Crabbe et al., 2006).  However, heterozygous expression introduces the possibility 
of “mixed channels” and compensation within the system, both of which can obscure the 
contribution of the studied channel.  A more direct method of investigation involves the 
use of highly specific GlyR modulators to investigate the behavioral effects of altering 
channel function.  
 
1.4 - GlyR Pharmacology 
In addition to ethanol, GlyR is modulated by a variety of other compounds.  As 
this list is quite extensive, this section will deal with only those most relevant to the work 
discussed in this thesis.  A full review of all known GlyR modulators has been compiled 
by (Lynch, 2004).  The locations of some of the GlyR α1 residues that are important for 




1.4.1 - Zinc 
Zinc (Zn2+) is essential for normal neural development and function, but can be 
toxic at high levels. Zn2+ is present in high concentrations throughout the brain, although 
most is protein-bound (Mathie et al., 2006).  However, the concentrations of free Zn2+ 
can range from 5 – 25 nM (Frederickson et al., 2006), and the concentrations in the 
synapse may exceed 100 µM (Vogt et al., 2000).  Zn2+ is packaged into vesicles and 
released along with neurotransmitters, including glycine (Birinyi et al., 2001), suggesting 
that it may function as a co-factor.  
The effect of Zn2+ on the GlyR is biphasic, making this ion a unique GlyR 
modulator.  At low concentrations (< 10 µM) Zn2+ potentiates glycine responses, while at 
higher concentrations, it has an inhibitory effect (Bloomenthal et al., 1994).  
Interestingly, Zn2+ does not have biphasic actions on the closely related GABAA 
receptors. 
Consistent with this biphasic behavior, two binding sites for Zn2+ have been 
identified in the ECD of the α subunit (pink residues in Figure 1.2). A series of 
histidines, a residue commonly involved in Zn2+ coordination on proteins, constitute the 
low affinity inhibitory site (Auld, 2001).  The substitution of H107 and H109 with 
alanine residues is sufficient to abolish Zn2+ inhibition (Harvey et al., 1999).  Threonine 
residues 112 and 133 are also thought to contribute to this site (Miller et al., 2005a).  
Mutational work suggests that this site is located between two subunits, suggesting that 
Zn2+ bound to this site inhibits GlyR function by stabilizing intersubunit interactions that 




removal of the hydrophobic interactions near this Zn2+ site that stabilize the closed state 
bias the receptor toward activation and antagonize the inhibitory effect of Zn2+.  Miller et 
al. (2008) found that the F99A mutation turned the GlyR into a Zn2+-activated channel 
that can open spontaneously in the absence of glycine.  
Traditionally, residue D80 is thought to be the principal player in the Zn2+ high 
affinity potentiating site.  While mutations to this residue can abolish Zn2+ potentiation 
(Laube et al., 2000), these effects are surprisingly ligand specific.  For example, channels 
with the D80A mutation will not show Zn2+ potentiation when the channel is activated by 
glycine; however, currents elicited by taurine are still enhanced by Zn2+ (Lynch et al., 
1998).  Mutations at three more residues (E192, D194, and H215) also significantly 
reduce or abolish Zn2+ potentiation (Miller et al., 2005b).  The potentiation of glycine-
mediated currents by Zn2+ is thought to result from a decrease in the rates of glycine 
unbinding (Laube et al., 2000), while a separate mechanism is proposed for taurine-
mediated currents.  Recently, intracellular Zn2+ was also shown to potentiate channel 
activity (Trombley et al., 2011). 
The abundance of Zn2+ in the CNS and the co-release of Zn2+ with glycine 
suggest that the interactions of Zn2+ with this channel are extremely important for 
channel function.  Indeed, homozygous knock-in mice carrying the D80A mutation 
exhibit phenotypes similar to those seen in human startle disease (Hirzel et al., 2006).  In 
addition, Zn2+ has also been shown to alter the effect of other GlyR modulators, most 





1.4.2 - Volatile Anesthetics 
Volatile anesthetics (VA) and several inhalants have also been shown to enhance 
GlyR responses (Mascia et al., 1996a; Beckstead et al., 2000).  The concentration of 
isoflurane, a common VA, required to achieve anesthesia is three times higher when the 
drug is applied to the brain alone as opposed to the spinal cord (Antognini and Schwartz, 
1993), suggesting that the spinal cord, in which GlyR is the dominant inhibitory ligand-
gated ion channel (LGIC), is a major anatomical target of anesthetics.  Several of the 
mutations that alter the GlyR sensitivity to ethanol also affect VAs (Mihic et al., 1997; 
Mascia et al., 2000).  Thus, ethanol and VAs are thought to have a similar and perhaps 
overlapping binding site (green residues in Figure 1.2). Functionally, the GlyR is 
implicated in the immobilizing effect of anesthetics.  The application of the GlyR 
antagonist strychnine, either intravenously or intrathecally, increases the amount of 
anesthetic required to induce immobility (Zhang et al., 2003). 
 
1.4.3 - Picrotoxin 
The plant alkaloid picrotoxin (PTX) has inhibitory effects on both GlyRs and 
GABARs, with a higher potency at the latter.  It is comprised of an equimolar mixture of 
picrotoxinin and picrotin, both of which are equally efficacious as GlyR inhibitors 
(Lynch et al., 1995).  On GABAA channels, PTX acts as a noncompetitive antagonist by 
blocking the pore (Newland and Cull-Candy, 1992).  A pore-blocking mechanism has 
also been suggested for GlyR; however, pharmacological studies found that PTX 




increased, suggesting an allosteric mode of action (Lynch et al., 1995).  Recent 
mutational studies support the hypothesis that PTX interacts with residues in or near the 
pore (Hawthorne and Lynch, 2005; Wang et al., 2007; Yang et al., 2007).   
Homomeric and heteromeric GlyR channels show different sensitivities to PTX.  
Heteromeric receptors require greater concentrations for the inhibitory effects to be seen, 
and this compound is often used to determine the type of channel present in 
electrophysiological studies (Pribilla et al., 1992).  Consistent with the hypothesized pore 
blocking mechanism, this difference in sensitivity between the α and β subunits is 
attributed to residues in the TM2 pore-lining region.   
Tutin, a picrotoxane molecule that shares many structural features with picrotoxin 
(Kudo et al., 1984), also modulates the GlyR.  Interestingly, this molecule has biphasic 
effects, similar to Zn2+, and is not affected by mutations in the pore region, suggesting a 
different mechanism of action (Fuentealba et al., 2011). 
 
1.4.4 - Strychnine 
Strychnine, another plant alkaloid, is a competitive antagonist at the glycine 
binding site that is often used to verify the contribution of GlyRs to the overall glycine-
mediated signal, as it does not affect glycine binding to its site on the N-methyl-D-
aspartate receptor (Young and Snyder, 1973).  Although this compound is often 
considered to be GlyR specific, at high concentrations is can also antagonize certain 
subtypes of GABAA (Houamed et al., 1984) and nACh channels (Matsubayashi et al., 




strychnine is thought to bind to a site that overlaps, but is not fully identical to, the 
glycine binding site (Marvizon et al., 1986; Ruiz-Gomez et al., 1990) (blue residues in 
Figure 1.2).  Residues from both subunit interfaces have been implicated in strychnine 
binding: R131 and E157 from the (-) face and Y202 and F207 from the (+) face 
(Grudzinska et al., 2005).  Recent modeling work based on the crystal structure of the 
Aplysia acytalcholine binding protein suggests that two strychnine molecules can co-
occupy the glycine binding site.  Mutations at residues that were shown to mediate single 
strychnine binding in this model (S158, F63, and R56) dramatically decreased the 
strychnine effect, while mutations at residues associated with the double-bound formation 
(F44, Q67, and F207) increased the response to strychnine (Brams et al., 2011).   
In an attempt to identify novel GlyR modulators, substances that shared structural 
similarities with strychnine were tested for their abilities to modulate the GlyR (Duan et 
al., 2009). While none of the compounds were as potent as strychnine, this study found 






Figure 1.2: Location of functionally important GlyR α1 amino acids. 
 
Illustration of a GlyR α1 subunit. Black residues in the ECD represent the two sets of cysteine 
residues that form disulfide bonds.  The brown residue marks the sole N-glycosolation site for 
this residue.  Yellow residues indicated natural GlyR mutants that result in spasmodic or 
hyperekplexia phenotypes.  Blue residues are important for strychnine binding and agonist 
affinity.  The green residues in TM2 and TM3 have been shown to mediate the effects of 
alcohols and volatile anesthetics. Pink residues mediate the modulatory effects of Zn2+.  The red 
residue in TM2 determines the main-state conductance of the channel, while the grey residues 
are thought to line the ion channel. Adapted from Laube et al., 2002. Modulation of glycine 
receptor function: a novel approach for therapeutic intervention at inhibitory synapses? Trends 





With the exception of strychnine, none of these modulators have any significant 
specificity for the GlyR.  Thus, the ability to selectively manipulate these receptors 
within complex systems is severely limited.  In addition, none of the currently known 
modulators are able to completely distinguish among the various a sub-types or a 
homomers and ab heteromers.  These channel subtypes have distinct localizations and 
kinetics, suggesting that subunit-specific modulators could have differential effects.  This 
limited pharmacology has hindered the characterization of GlyR function, leaving an 
important gap in our understanding of how these channels contribute to various disease 
states and phenotypes. 
 
1.5 - Phage Display 
In order to address the lack of GlyR-specific compounds, various approaches have 
been used in an attempt to identify novel GlyR modulators.  These include generating 
modified versions of known GlyR modulators (Duan et al., 2009) and blind chemical 
screens (Gilbert et al., 2009).  However, screens based on an existing modulator are 
typically limited in their diversity, while chemical screens yield a high percentage of false 
positives (background noise) that must be sorted through.  A more efficient approach 
would be to use a selection system that allows for the direct isolation of compounds 
based on their affinity for the GlyR with a high initial diversity and the ability to limit or 
remove non-specific hits.  Phage display (PD) can be used to identify small peptides that 




that infect bacterial cells and use the host machinery to replicate.  Commercially available 
phage libraries contain billions of peptide sequences, making this a very high throughput 
approach.  Furthermore, linking affinity selection to a biological system allows for a 
series of selection steps to reduce the contribution of non-specific binding. 
 
1.5.1 - Phage Structure 
While several types of phage have been used for PD, the most common is the 
M13 viron, which has been extensively characterized.  Each individual phage consists of 
five surface coat proteins that encapsulate a circular single-stranded DNA, forming a 
long, slender rod shape (Figure 1.3).  The majority of the phage body is comprised of 
pVIII proteins.  These proteins have a positively charged helix on their C-termini that 
interacts with the encapsulated DNA (Marvin, 1998).  Hydrophobic interactions allow 
these proteins to package together tightly, forming a long cylinder.  One end of the viron 
is capped with pairs of the minor coat proteins pVII and pIX, while the other end is 
capped with pairs of pIII and pVI proteins.  Proteins VII and IX are small hydrophobic 
proteins that are involved in the initiation of phage assembly within the host cell 
(Rakonjac et al., 2011).  On the distal end of the phage, pIII is required for infectivity and 








Figure 1.3:  Structure of filamentous phage Ff 
 
(A) Transmission electron micrograph of a phage (original magnification 57,000x). (B) Illustration 
of a phage showing the arrangement of the major coat protein (yellow) and the four minor coat 
proteins. Inset – Major coat protein surface domains represented as electron densities. Adapted 
from Brigati et al., 2008. Phage display for generating peptide reagents. Curr. Protoc. Protein Sci. 




1.5.2 - Phage Replication 
M13 phage infect a wide variety of gram-negative bacteria as part of their 
reproductive cycle.  These cells are non-lytic, although infection does substantially slow 
down the replication of the host cell (Marvin and Hohn, 1969).  Host infection involves 
two major steps: recognition, during which the virus binds to the bacterial cell surface 
receptor, and translocation, in which the viral DNA is uncoated and translocated into the 
bacterial cell cytoplasm.  The pIII coat protein mediates the initial steps of phage 
replication.  Protein III contains three distinct domains (CT, N1, and N2) connected by 
glycine-rich linkers, which allow portions of pIII to be somewhat flexible.  The two 
amino-terminal domains (N1 and N2) are required for phage infection of a host cell and 
have been extensively characterized using electron microscopy and crystallography 
(Holliger and Riechmann, 1997; Gray et al., 1981; Holliger et al., 1999; Lubkowski et al., 
1998).  During recognition, the N2 domain of pIII binds to the endogenous F-pilus on the 
surface of the bacterial cell (Click and Webster, 1997).  The pilus is then retracted into 
the cell membrane.  This brings the phage in contact with the secondary receptor, a Tol 
complex comprised of TolA, TolQ, and TolR that resides in the periplasm of the bacterial 
membrane (Lubkowski et al., 1999).  This complex is highly conserved in gram negative 
bacteria and is part of a larger trans-envelope Tol-Pal complex that is involved in cell 
division and the maintenance of cell envelope integrity (Gerding et al., 2007).  The 
retraction cycle of the bacterial pili are spontaneous rather than a result of phage binding 
(Clarke et al., 2008); however, following successful infection pilus assembly is inhibited 




phage.  The N1 domain of the phage interacts with the D3 domain of TolA, resulting in 
the entry of phage DNA into the cytoplasm and the integration of the major coat proteins 
into the inner membrane of the bacterial host. The exact mechanisms behind the 
translocation of the viral DNA into the host cell are largely unknown. However, it is 
hypothesized that the CT domain of pIII may be involved in the formation of a pore 
through which the viral DNA may pass (Glaser-Wuttke et al., 1989).  Specifically, a 
conformation change in the CT domain may cause an uncapping of the viron, exposing 
the hydrophobic surfaces of pIII, pVI, and pVIII, similar to the mechanism of entry seen 
in eukaryotic viruses (White, 1992; Bennett and Rakonjac, 2006).  
 
1.5.3 - Synthesis of Phage Proteins within the Host 
Once inside the host cell, bacterial host enzymes synthesize the complementary 
(−) strand from the original ssDNA (+) strand, producing a double-stranded, covalently 
closed, supercoiled DNA product referred to as the replicative form (RF).  RNA 
polymerase binds to the (+) strand, synthesizes RNA on the ssDNA template, stalls at the 
poly-G tract, backtracks, and finally dissociates from the template, leaving an RNA 
primer hybridized to the template strand (Zenkin et al., 2006).  DNA polymerase III uses 
this primer to synthesize the (-) strand, resulting in a double stranded circle.  The RF 
DNA then replicates to form a pool of approximately 100 RF molecules.  These RF DNA 
molecules act as templates for the synthesis of progeny ssDNA.  
The phage genome contains nine genes that encode for eleven proteins, the five 




pII, pIV, pV, pX and pXI).  Transcription of the (-) strand produces the eleven coded 
proteins in the order in which they are required for assembly.  Multiple transcripts are 
produced, allowing for the production of large amounts of coat proteins.  The replication 
proteins (pII, pV, and pX) are synthesized and remain in the cytoplasm, while the 
structural proteins are inserted into the host membrane (Endemann and Model, 1995).  
The replication protein, pII, binds to a the supercoiled RF and cleaves the (+) strand, 
covalently binding to the 5’ end (Asano et al., 1999).  DNA polymerase binds to the 3’ 
end and synthesized a new (+) strand (Meyer and Geider, 1982).  In the early stages of 
phage infection, the new (+) strand is used to generate more (-) strands, increasing the 
number of RF and thus the number of translated phage proteins.  This process ceases 
when enough pV is generated to fully coat the new (+) strands (Zaman et al., 1992).  The 
ssDNA is fully encased in pV with the exception of a hairpin loop, which serves as the 
packaging signal.  Protein V also inhibits the translation of pII (Michel and Zinder, 
1989), thus it coordinates ssDNA production and packaging. 
 An assembly complex, composed of pI, pIV, pIX, and thioredoxin from the host 
cell, is formed near adhesion zones in the host membrane.  At these locations, the inner 
and outer membrane of the host cell are closer together (Lopez and Webster, 1985).  
Protein IV spans the outer membrane, while pI and pXI form a channel that spans the 
inner membrane and has ATPase activity (Horabin and Webster, 1988).  The amino 
terminal of pI and thioredoxin occupy the cytoplasmic portion (Russel, 1993).  Protein 
VII and pIX, which will eventually cap the distal portion of the viron, plug the channel 




assembly and a pathway for non-lytic viral exit from the host cell.  The exposed 
packaging signal targets the pV-ssDNA to this complex to begin viron elongation (Russel 
and Model, 1989). 
Elongation of the phage particle requires pIII, pVI, pVII, pVIII and pIX to be 
embedded in the inner membrane with thioredoxin (Russel, 1991).  While the exact role 
of thioredoxin is unknown, it is hypothesized to form a complex with pI that enhances 
phage production by stabilizing the binding of pI to the viral DNA (Russel, 1995).  For 
the phage particle to assemble, pV must be stripped from the ssDNA and replaced with 
rings of pVIII.  The hydrolysis of ATP by pI is thought to provide the energy for 
displacing pV from the ssDNA.  
Assembly termination occurs when the entire phage ssDNA is packaged in pVIII.  
At this point, pIII and pIV, which are embedded in the host membrane, are added to the 
proximal end.  Protein IV is required to stabilize the proximal end and attach pIII.  A 
conformational shift in pIII following this attachment is suggested to be the driving force 







Filamentous Bacteriophage   57
Model, 1995; Marciano et al., 1999; Rapoza and Webster, 
1995). The positive and negative origins of replication, as 
well as the packaging signal or morphogenetic signal, are 
 After entry into the cytoplasm, the Ff ssDNA genome 
positive (+) strand serves as a template to synthesize the 
negative (-) strand. This step is independent of phage 
proteins, and is initiated by host RNA polymerase. The 
negative origin, which forms two stem-loop structures 
resembling -35 and -10 promoter sequences, serves as 
a starting site for host RNA polymerase to synthesize a 
primer (Higashitani et al., 1997). Following binding to this 
promoter mimic, the polymerase synthesizes RNA on the 
ssDNA template, then stalls at a poly-G tract, backtracks 
and dissociates from the template, leaving an RNA primer 
2006). Host DNA polymerase III then uses this primer to 
synthesize the (-) strand of DNA, yielding a double-stranded 
circle. The negative strand origin is not absolutely required 
for phage replication. An RNA primer for DNA replication 
can be synthesized at other locations in the genome, albeit 
 The Ff phage replicate by a rolling-circle mechanism, 
one strand at a time (Figure 3). The dsDNA form of the 
Figure 3. The Ff phage life cycle.
coat protein integrates into the inner membrane. Synthesis of the negative (-) strand is initiated at the negative strand origin of 
replication by RNA polymerase, which generates an RNA primer and is then released from the template (Zenkin et al., 2006). 
Host DNA polymerase III uses this primer to replicate the complete negative strand. Positive strand synthesis is initiated by pII 
(gray circle), which creates a nick in the + strand of the dsDNA replicative for at the positive origin of replication. Supercoiling 
Rolling circle replication then ensues, one strand at a time. During the initial period of viral infection, new positive strands 
are used as templates for synthesis of negative strands, resulting in an increase in copy number of the dsDNA replicative 
into the membrane prior to their assembly into phage particles. Later in the infection, positive strands are coated by dimers of 
is drawn based on the cryo-EM structure of the type III secretion system (Marlovits et al., 2004).
	  
Figure 1.4: Reproductive cycle of Ff phage 
 
Diagram illustrating the infection, replication, and release of Ff phage.  Phage interact 
with cell surface proteins and the ssDNA of the phage is translocated into the cytoplasm of 
the host cell. During early infection, new positive strands are used as templates for the 
synthesis of negative strands, resulting in an increase in the levels of the double stranded 
RF DNA.  These RF strands are then used to produce phage proteins.  In the later stages of 
infection, the new positive strands are coated with pV, transported to the membrane, and 
packaged in pVIII and released from the host cell. Adapted from Rakonjac et al. 2011. 
Filamentous bacteriophage: biology, phage display and nanotechnology applications.  




1.5.4 – The Development of Phage Display 
 In 1985, it was discovered that the DNA of these organisms are able to tolerate 
the insertion of sequences for small peptides (Smith and Petrenko, 1997). The foreign 
coding sequence was spliced in-frame into a phage coat protein gene so that the coded 
peptide was fused to the coat protein, and thus displayed on the viron surface (Smith, 
1985).  This original work was done using f1 phage to express a 57 amino acid segment 
of EcoRI.  Following replication of the virons in bacteria, the progeny were found to 
carry the inserted sequence.  However, this display vector had several limitations.  The 
bacterial plaques formed by the infected cells were very small, and the phage carrying the 
peptide insert were significantly less infective that their wild-type counter parts.  These 
limitations arose from the placement of the peptide insert into a loop in the D2 domain of 
pIII, which interfered with the ability of the phage to infect bacterial hosts.  A more 
functional library was developed using fd-tet phage in which the foreign sequence was 
expressed on the amino-terminal of pIII (Zacher et al., 1980).  This vector has the 
advantage of built in tetracycline resistance.  However, the DNA copy number for this 
system was low due to the fact that the tetracycline resistant insert disrupted the origin of 
the (-) strand, forcing the phage to use an alternative pathway for synthesis.  Thus, 
infectivity in this library was low (reduced 10-fold from wild-type), which in turn 
reduced the phage particle yield following amplification (reduced 40-fold from wild-
type). 
 The dominant family of phage vectors in use today is the M13mp series (Messing 




peptide of the enzyme β-galactosidase.  This peptide segment, referred to as the α 
peptide, has no enzymatic activity on its own, but is capable of restoring enzymatic 
activity that is lost due to a specific deletion in the lacZ gene that removes the α domain 
of the N-terminus of β-galactosidase (deletion ΔM15).  Thus, when phage carrying this 
vector are grown using a plating medium that contains X-gal, the chromogenic substrate 
of β-galactosidase, using a bacterial host carrying the ΔM15 deletion, the plaques of 
infected cells are blue due to the rescue of β-galactosidase activity by the a protein, while 
uninfected bacterial colonies remain colorless.  This allows for easy isolation of infected 
colonies even when the plaque size is reduced.  The M13KE vector used to develop the 
commercially available phage libraries discussed in this thesis is derived from M13mp19. 
 
1.5.5 – Library Diversity 
The biology-based approach used in phage display has several advantages over 
binding assays that utilize chemical libraries.  Most importantly, the genotype and 
phenotype remain linked throughout the amplification steps.  This means that the 
isolation of a single phage-bound peptide will allow for the full characterization of that 
peptide.  However, utilizing a living system also comes with some inherent 
disadvantages.  The composition of the peptide expressed on the phage can significantly 
alter the phage-host interaction, and thus the ability of the phage to replicate (Pratt et al., 
1966).  This can lead to a bias against sequences that significantly slow the 
morphogenesis of the virus, as these will be selected out of the library (Rodi et al., 2002).  




commercially available libraries, while proline, threonine, and histidine are over-
represented.  Due to their ability to cross-link with one another, cysteine residues have 
the potential to form dimers with other cysteine-containing proteins in the periplasm 
(Haigh and Webster, 1998).  In addition to the intermolecular interactions, cysteines can 
cross-react within a peptide, leading to misfolding.  As a result, peptides carrying odd 
numbers of cysteine residues do not exist in these libraries (Kay et al., 1993).  Proline 
residues, on the other hand, are often overly expressed in pIII libraries. This is possibly 
due to the fact that these residues instigate β-turns in the protein, a shape that is preferred 
over purely α-helical structures by the enzyme that removes the pIII signal sequence, 
signal peptidase (Malik et al., 1998).  Thus, the conformational nature of the incorporated 
peptide can influence the inclusion of that peptide sequence into the general library.  
Charged residues are also a source of library bias, the most prominent being a lack of 
arginine residues at the beginning of the peptide.  Positive charges at the amino-terminus 
are thought to reduce transport across the membrane (Yamane and Mizushima, 1988) and 
alter interactions with SecY proteins (Peters et al., 1994), which insert the pIII into the 
membrane (Boeke et al., 1982).  Thus arginine residues are typically absent from the first 
position within the peptide, which lies immediately after the signal sequence.  
While individual residue restrictions do impact the diversity of the library, the 
major factor limiting peptide expression is the redundancy of the genetic code.  Certain 
residues are coded for by multiple codons, which biases their expression in a library built 
using degenerate oligonucleotides.  Based on the number of redundant sequences, the 




represented, to approximately 11.8%.  Adding in the restrictions on individual amino 
acids discussed above, the diversity of a library containing 12 randomized amino acids is 
estimated to be around 4.4% (Rodi et al., 2002).  In spite of these restrictions, each 
library still contains several billion sequences; however, these sequence limitations 
should be taken into account when analyzing phage display data. 
 
1.5.6 - Introduction of a Randomized Peptide Insert 
The foreign peptide inserted into the phage can be derived from natural sources or 
be a deliberately designed synthetic sequence.  Most commercially available libraries are 
constructed using saturation mutagenesis, which allows for the highly controlled 
introduction of mutations into a protein sequence.  This approach replaces existing 
codons with degenerate oligonucleotides that code for multiple amino acids.  For 
example, the NNN codon contains all 64 natural codons.  However, as previously 
discussed, the redundancy in the genetic code leads to heavy sequence bias in libraries 
constructed with this codon.  In a less redundant alternative, the third codon is restricted 
to coding for either a G or C (NNK), resulting in 32 unique codons and a reduction in the 
impact of redundancy.  This codon is used in the production of the libraries used in this 
thesis.  This form of randomization is most successful when a thorough search of a 
localized region is required (Devlin et al., 1990; Cwirla et al., 1990).  Theoretically, the 
diversity of the library will increase exponentially with the number of residues 
randomized.  However, in reality the diversity is limited by factors affecting bacterial 




be simultaneously randomized in this manner with a reasonable probability of 
representing all possible combinations (Clackson and Wells, 1994).  The libraries used 
for this study are predicted to have complexities on the order of 109.  In a library with 7 
randomized amino acids, this is sufficient to encode most of the possible combinations 
(1.28 x 109).  However, in libraries carrying 12 amino acid peptides, this represents only 
a tiny fraction of the possible combinations (4.1 x 1015).  
To produce libraries from synthetic DNA, it is necessary to insert the DNA into a 
suitable vector and introduce the recombinant DNA into a bacterial host to initiate phage 
production.  There are a variety of approaches for integrating synthetic DNA into the 
phage genome.  The simplest involves taking advantage of the ssDNA carried by the 
phage.  Phage ssDNA is easy to purify at a high yield and can serve as a template for 
oligonucleotide-directed mutagenesis (Sidhu et al., 2000).  The designed oligonucleotide 
is annealed to the ssDNA template and enzymatically extended and ligated.  This 
produces a dsDNA heteroplex in which one strand corresponds to the original phage 
DNA and the other carries the inserted peptide sequence.  Original attempts to use 
ssDNA mutagenesis (Zoller and Smith, 1983; 1982) suffered from low mutation 
frequencies.  This was due to the preference of the E. coli bacterial host for the parental 
(non-mutated) DNA strand. This problem was rectified following the production of 
template ssDNA from dut-/vng- E. coli strains (Kunkel, 1985; Kunkel et al., 1987).  
Template strands generated from these cells contain a significant amount of uracil bases 
in place of thymine bases.  When dsDNA heteroplexes containing these parent strands are 




uracil-containing parent strand, increasing the production of the synthetic strand carrying 
the foreign peptide sequence. 
Though all of the major coat proteins have been used to develop phage libraries, 
expression on the pIII protein is most common.  The amino terminus of N1 extends out 
away from the phage body in such a way that peptides expressed on this region are 
exposed to the environment.  This accessibility enables the scanning of peptide affinity 
for presented targets.  Although pIII plays a major role in the infection and replication 
process of these virons, expression at the amino-terminus places the foreign peptide away 
from the TolA binding site and the N2 domain (Lubkowski et al., 1999), thus infectivity 
is not significantly impaired.  
 
1.5.7 – Phage Selection: “Biopanning” 
Successful peptide selection relies on the ability to separate phage carrying 
sequences with affinity for a desired target from the general library population. This 
requires the target to be presented in a native form at a sufficient concentration to allow 
for the enrichment of binding sequences.  Typically, the target of interest is immobilized, 
either using a solid support or adherent cell expression, and the phage library is washed 
on, allowing those phage carrying peptides with affinity for the target to bind.  Following 
a series of washes to remove the non-binding phage, the bound phage can be eluted using 
a competitive ligand for the target or exposure to low pH, to which the phage are 
resistant.  The collected phage can then be amplified in bacteria, allowing for several 




establishes a link between the genotype and phenotype of these phage.  Each phage will 
pass on its entire genome, including the foreign peptide sequence, to its progeny.  This 
enables phage to be used for several rounds of selection and amplification, an important 
advantage over chemical-based affinity selections.  However, amplification can introduce 
a replication bias.  That is, phage carrying peptides that randomly increase their 
infectivity or any insertless phage left over from the original library will grow more 
quickly.  This is particularly problematic for phage libraries with induced structural 
constraints.  Thus, the selection process is a mixture of display level and binding affinity.  
 
1.5.8 – Utilization of Phage Display 
PD has been used in a variety of fields to identify binding motifs, cell-specific 
peptides, and peptides that bind to and modulate several cellular proteins.  In addition to 
fully randomized peptides, libraries based on existing proteins have also been developed.  
The first proteins to be cloned for PD were antibody fragments (McCafferty et al., 1990).  
Both “natural” antibodies derived from donor B cells (Clackson et al., 1991) and 
synthetic antibodies in which a random sequence has been inserted into the 
complementary determining region (Hoogenboom and Winter, 1992) have been used for 
successful PD selection.  
Libraries based on known ligands have also been developed.  This approach 
typically involves introducing random mutations throughout the ligand (Cain et al., 
2000), introducing targeted mutations to specific regions of the ligand (Cabibbo et al., 




homologous family (Stemmer, 1994).  This technique was recently used to identify a 
scorpion toxin-based modulator of the Kv1.3 channel (Takacs et al., 2009).  Different 
versions of PD have been used to identify therapeutic recombinant antibodies (Bradbury 
and Marks, 2004), modify the properties of known proteins (Rebar and Pabo, 1994), and 
identify peptides that target specific tissue or cell types (Pasqualini and Ruoslahti, 1996). 
Most relevant to this work, PD based on random peptide sequences has been used 
to isolate peptides that show affinity for ion channel targets and modulate their function.  
Some of the most striking examples include agonists that show nanomolar potency at the 
erythopoetin (Wrighton et al., 1996), thrombopoetin (Cwirla et al., 1997), and fibroblast 
growth factor receptors (Ballinger et al., 1999).  In addition, peptides have been identified 
that bind to the selected target and alter the effects of other modulators.  For example, 
Balass et al. identified a peptide that binds to the nAChR at the α-bungarotoxin binding 
site, thus preventing the binding of this toxin (Balass et al., 1997).  A peptide that acts as 
a non-competitive inhibitor of the N-methyl-D-aspartate receptor was also identified 
using PD (Li et al., 1996).  The successful application of PD in the identification of 
channel modulators supports the hypothesis that PD can be used to identify peptides that 
will bind to and modulate the GlyR.   
 
1.6 - Channel Modulation 
As the bulk of this thesis will deal with the identification and characterization of 
compounds that modulate channel function, a brief discussion of the terms and 




The discussions here will largely deal with two distinct classes of agents: those 
that bind to and directly activate the channel (orthosteric agents) and those that merely 
modulate the function elicited by the primary agonist (allosteric agents). In general, 
orthosteric agents produce significant perturbations of the transduction mechanism 
(leading to channel opening), while allosteric agents fine-tune the corresponding 
neurotransmission without opening the channel on their own (Maksay, 2009).  There are, 
of course, grey areas in this field, and what exactly constitutes an orthosteric modulator 
versus an allosteric modulator is the subject of some debate (Schwartz and Holst, 2007).  
For example, a recent report demonstrated that α7 nACh receptors can be activated 
following binding to what has been traditionally recognized as an allosteric site (Gill et 
al., 2011).  However, for the purposes of this thesis, a modulator that can produce 
activation of the channel on its own will be referred to as an orthosteric ligand, while a 
modulator that has no effect on its own but modulates the effect elicited by another ligand 
will be referred to as an allosteric modulator. 
As previously discussed, channel activation involves the binding of a ligand that 
triggers a conformational wave ultimately leading to gating and channel opening.  While 
an explanation of the detailed mechanisms of this effect are beyond the scope of this 
thesis, it is important to note the major contributors.  All ligands, and indeed all channel 
modulators of any type, have two major characteristics that determine the magnitude of 
their effects: affinity for the target and efficacy observed after binding.  Affinity refers 
specifically to the tightness of binding of the compound to the receptor, while efficacy 




altering the structure of the channel in some way.  Together these components cause a 
change in receptor function, and an increase or decrease in either will alter the observed 
effect.  Affinity and efficacy are intimately linked, and determining if an allosteric 
modulator affects the affinity or the efficacy of a given orthosteric ligand is incredibly 
difficult (Colquhoun, 1998).  In this thesis, the preliminary selection process, phage 
display, gives a measure of affinity only.  The peptides are selected purely on their ability 
to bind to the receptor, regardless of the effect on channel function.  However, the 
estimated affinity from this selection process may or may not relate to the final 
modulatory effect seen in the functional assay, as this response is a combination of 





1.7 – Chapter Overview 
 The remainder of this dissertation will be divided into four chapters.  Chapter 2 
details the materials used in these experiments as well as the methods applied and the 
data analysis procedures.  The primary techniques employed are phage display panning 
and whole-cell two-electrode electrophysiology. 
 Chapter 3 describes the results of the experiments used to test the hypothesis that 
phage display can be used to identify peptides that bind to the GlyR.  Phage display has 
been successfully used to isolate peptides that have affinity for ion channels and 
receptors.  We developed a modified phage panning protocol to allow for the selection of 
peptides that bound to the extracellular domain of the α1 GlyR, and several peptides were 
identified using this approach.  In addition, these experiments also tested the hypothesis 
that some of these phage-derived peptides would have modulatory effects on GlyR 
function.  Using two-electrode physiology, we found several peptides that modulated the 
glycine responses of α1 GlyR, some with high specificity. 
 Chapter 4 describes the results of experiments in which the specificity of the 
panning procedure was increased.  These experiments tested the hypothesis that the 
phage display protocol used to identify peptides that bind to and modulate α1 GlyR can 
be modified to bias selection toward peptides that differentiate between GlyR subtypes.  
By including two GlyR subtypes (α2β and α3β) in the negative selection portion of the 
panning procedure, we identified several peptides that show preferential modulation of 




 Chapter 5 describes experiments designed to test the hypothesis that a common 
peptide contaminant, trifluoroacetic acid (TFA), also has modulatory effects on GlyR 
function.  It was determined that TFA not only alters the response to glycine in these 
channels, but does so in a subtype-specific manner. 
 Chapter 6 is an overall discussion of the results of the experiments outlined in the 
preceding chapters.  General conclusions regarding the utility of the phage protocol and 
peptides used in these studies as well as proposed directions for future studies are 





2.0 | MATERIALS AND METHODS 
This chapter contains detailed descriptions of the experimental procedures and 
materials used in the following chapters.  A summary of the methods used for individual 
experiments can be found in the methods section of the appropriate chapter. 
 
2.1 - Preparation of cDNA Clones 
The cDNA for human GlyR α1 and β subunits and GABAA α1 subunit were 
previously subcloned into a modified pBK-CMV vector lacking the coding for the lac 
promotor and the lacZ start codon.  The plasmid contains a cytomegalovirus (CMV) 
promotor as well as a gene conferring resistance to the antibiotic kanamycin and enables 
the expression of these subunits in heterologous expression systems.  The cDNA for the 
α2 subunit was cloned in the laboratory of Dr. Neil Harrison and placed into the pCSII 
vector, which contains a gene for ampicillin resistance. The GABAA β2 and γ2 subunits 
and the GABAC ρ1 subunit were also cloned into this vector by Paul Whiting at Merck.  
The rat α3 subunit was cloned into the pTracer-CMV2 vector in the laboratory of Dr. 
Heinrich Betz. The cDNAs were isolated from XL1-Blue E. coli (Stratagene) 
transformed with the respective GlyR plasmid.  Bacterial colonies were then grown on 
agar plates containing 50 mg/ml kanamycin in order to select for successfully 
transformed cells.  Individual colonies from these plates were grown in LB broth 
overnight in a shaker incubator.  GlyR cDNA was then isolated from the bacterial cells 




Valencia, CA).  The concentration and quality of the collected plasmids were determined 
using a NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE).  Samples 
with an A260/A280 ratio near 1.8 were considered suitable for use.  
 
2.2 - Site Directed Mutagenesis 
Custom oligonucleotide primers were designed using the NetPrimer primer design 
program (Premier Biosoft) containing the desired mutations and obtained from Integrated 
DNA Technologies (Coralville, IA).  Primers were designed to be 35 – 45 base length 
sequences with more than 60% GC content, a melting point (Tm) greater than 78oC, and a 
minimal possibility for intraplasmid loop formation (Liu and Lovinger, 2000).  All 
mutants were made using the a1 GlyR cDNA as the template and the Stratagene (Cedar 
Creek, TX) QuickChange Mutagenesis Kit.  The forward and reverse primers (125 ng/ml) 
were individually combined with the template a1 cDNA (25 ng/ml), nucleotide tri 
phophates, and Taq DNA polymerase and run through the first 15 cycles of a 
thermocycling protocol in a PTC-100 thermocycler.   The forward and reverse mixtures 
were then combined 1:1 and run together for the remainder of the protocol (additional 15 
cycles).  Linear amplification was used: denaturing of template cDNA at 95oC, annealing 
of the primer at 55oC, extension from the 3’ end at 68oC.  The cycle was repeated a total 
of 30 times and then the temperature was held at 4oC.  To isolate the newly mutated 
DNA, the entire product was then digested with the DpnI restriction enzyme to remove 




described above.  Samples of the amplified DNA were sent for sequencing using a 
dideoxy fluorophore method to verify the incorporation of the desired mutation.  
 
2.3 - HEK Cell Culture 
Human Embryonic Kidney (HEK) 293 cells were obtained from American Type 
Culture Collection (Manassas, VA).  Cells were stored in liquid nitrogen.  Before they 
were used in the phage panning, cells were thawed and grown according to standard 
procedures (Freshney, 2002) for three cycles.  Cells were cultured with Dulbecco’s 
modified Eagle’s medium with L-glutamine, sodium pyruvate supplemented with 10% 
fetal bovine serum, Glutamax, and PenStrep (Invitrogen, Carlsbad, CA) and kept at 37oC 
in a 5% CO2 atmosphere.  Cell lines were split every 5 days with 5% trypsin/EDTA in 
Hank’s balanced salt solution (Invitrogen) for 25 cycles, after which new aliquots of early 
passage cells were started.  Cells were transfected with 8 mg of GlyR cDNA using either 
the PolyFect reagent (Quiagen, Valencia, CA) or the Lipofectamine2000 reagent 
(Invitrogen).  Untransfected control cells were exposed to the transfection reagent in the 
absence of GlyR cDNA.  All cells were incubated for 48 h prior to use. 
 
2.4 - Phage Display Panning 
Phage display libraries expressing peptides that were 12 (D12) or 7 (D7) amino 





On panning day one, the first negative selection plate (untransfected HEK cells 
for the D12 library or α2β/α3β GlyR expressing plates for the D7 library) was washed 
three times with 0.01 M phosphate-buffered saline (PBS) containing 8.2 mM NaPO4, 1.5 
mM KH2PO4, 137 mM NaCl, and 2.7 mM KCl with 1.5% bovine serum albumin (BSA) 
and 0.1% Tween-20 (PBS/BSA-T).  A 10-mL aliquot of the phage library (containing 2 x 
1011 phage particles) was diluted in 1 ml of PBS/BSA-T and applied to the negative 
control plate.  The cells were incubated with the phage at room temperature for 30 min 
with continuous rocking.  Phage that did not bind in the negative control plate were 
removed with a pipette.  For the experiments using the D7 library, these phage were 
applied to the second negative control plate expressing the control channel that was not 
expressed in the first negative control plate (α2β/α3β) and the negative selection process 
was repeated.  The non-binding phage were then applied to a plate of target-expressing 
cells (GlyR α1 for the D12 experiments, GlyR α1β for the D7 experiments) and 
incubated for 60 min at room temperature with constant rocking.  The non-binding phage 
from this positive selection were discarded, and the plate was washed five times with 
PBS/BSA-T. The bound phage were eluted by lowering the pH using 0.2 M glycine HCl 
(10 M HCl buffered to pH 2.2 with glycine) with 1 mg/ml BSA.  Plates were incubated 
with this elution buffer for 10 min at room temperature.  The eluate was removed and 
neutralized with 150 ml of 1M Tris-HCl (pH 9.0).  Samples of the eluate were taken for 
titering (10 ml), and the remainder was added to 20 ml of E. coli (A600) in LB broth for 
amplification.  After 4.5 h of incubation, the bacterial culture was transferred to a 50-ml 




transferred to a fresh tube and respun.  The upper 80% of the supernatant was again 
transferred to a fresh tube, and a one-sixth volume of polyethylene glycol (PEG)/NaCl 
(20% w/v PEG 8000 and 2.5 M NaCl) was added.  Phage were allowed to precipitate 
overnight at 4oC. 
On panning day two, the PEG precipitates were spun at 10,000 rpm for 15 min at 
4oC. The supernatant was discarded and the precipitate was spun again.  Residual 
supernatant was removed using a pipette.  The pellet was resuspended in 1 ml of Tris-
buffered saline (50 mM Tris-HCl pH 7.5 and 150 mM NaCl), transferred to a 1.7-ml 
microcentrifuge tube, and spun at 10,000 rpm for 5 min at 4oC.  The supernatant was 
transferred to a fresh microcentrifuge tube, and the suspended phage were precipitated 
with PEG/NaCl on ice for 60 min.  The phage were spun at 10,000 rpm for 10 min at 4oC, 
and the supernatant was discarded.  The pellet was resuspended in Tris-buffered saline 
and spun again for 1 min.  The supernatant was then transferred to a fresh tube and stored 
at 4oC.  Aliquots of the amplified phage were placed in bacteria (A600) and titered at three 
consecutive dilutions.  
For successive panning rounds, the amplified phage were diluted to 2 x 1011 in 1 
ml of PBS/BSA-T.  If the amplified phage count was lower than 1011, dilutions as low as 
109 could be used.  After several panning rounds (five for the D12 library, seven for the 
D7 library), individual plaques from the most recent titer plates were isolated and 
incubated overnight in 1 ml LB broth at 37oC with agitation.  The overnight culture was 
then purified using the S.N.A.P. MiniPrep kit (Invitrogen) according to the 




sequence primer (New England Biolabs), and the sequences of the fusion peptides were 
recorded.  Peptides were synthesized by Peptide 2.0 Inc (Chantilly, VA). 
 
2.5 - Oocyte Isolation and Injection 
Xenopus laevis frogs purchased from Xenopus Express (Homosassa, FL) were 
housed at 19oC on a 12-hour light/dark cycle.  The oocytes were surgically removed from 
anesthetized animals via a small incision in the lower abdomen.  Following surgery, the 
incision was sutured closed and the frog was allowed to recover.  Each animal was used 
for up to three surgeries.  
Prior to injection, three outer membranes must be removed from the oocytes. 
Stage V and VI oocytes were placed in a hypertonic isolation solution, which allowed for 
the separation of the outer oocyte membranes so that the thecal and epithelial layers could 
be removed using forceps.  The oocytes were then exposed to a 0.5 mg/ml type 1A 
collagenase buffer (Sigma) for 15 min to remove the follicular membrane.  The isolated 
oocytes were then placed in an isotonic solution, modified Barth’s saline (MBS). 
The cDNAs used for oocyte injections were prepared as described above.  cDNA 
stocks were diluted to 50 ng/ml in sterile deionized water (diH2O).  A capillary glass 
injector tip was made using a Sutter Instruments P-30 Flaming/Brown puller.  The 
injector was backfilled with mineral oil and placed on a Drummond Nanoject II injector.  
This injector was used to front load 1 ml of the diluted cDNA.  Using the “blind” 
injection method of Coleman (1984), cDNA was injected into the animal poles of the 




incubation media that had been sterilized using a 0.22-mm filter.  Expression was 
typically seen within 48 h, and all electrophysiological data were recorded within 2-6 
days of cDNA injection. 
 
2.6 - Two-electrode Voltage-clamp Recordings from Xenopus Oocytes 
 Currents were recorded from Xenopus oocytes heterologously expressing GlyRs 
or GABARs using a Warner Instruments OC-725C Oocyte two-electrode voltage clamp. 
Two high resistance (0.5 – 10 MW) electrodes were pulled from capillary glass (FHC) 
using a Sutter Instrument P-30 puller and then filled with 3 M KCl. Solutions of MBS or 
MBS + drug (pH 7.5) were perfused into the chamber at a rate of 2 ml/min using a 
peristaltic pump (Cole Parmer Instrument Co, Vernon Hills, IL).  Excess fluids were 
removed from the chamber by a waste line.  Oocytes were placed in a small well within 
the recording chamber and impaled in the animal pole with both electrodes.  One 
electrode measures the voltage of the oocyte membrane, while the other injects the 
necessary current to maintain the desired potential (-70 mV).  When the channels 
expressed by the oocyte open, the channel allows chloride ions to flow outward.  This 
flux is detected by the voltage electrode as a depolarizing force, which causes the current 
electrode to inject negative current in order to hold the command voltage.  This feedback 
occurs continuously and the output (the injected current required to counteract the flux of 
chloride ions) is recorded using either a paper chart recorder (Cole Parmer) or digitized 
using a PowerLab 4/30 digitizer (ADInstruments) and recorded on a PC laptop (Dell) 





2.7 - Analysis of Macroscopic Currents 
The peak amplitudes of the macroscopic currents resulting from GlyR or GABAR 
activation were either measured manually from chart recorder paper or digitally from the 
LabChart file.  These values were corrected for the baseline current and recorded in an 
Excel spreadsheet (Microsoft, Redmond, WA).  Peptide or drug effects were calculated 
as percent changes compared with the effects produced by glycine or GABA alone.  
These values were grouped by condition and the mean and standard error of the mean 
were calculated.  To determine statistical significance, the percent enhancement or 
inhibition values obtained in the presence of peptide or drug were compared by either a t-
test or one- or two-way analysis of variance, as indicated, with a criterion of p < 0.05 





3.0 | IDENTIFICATION OF A NOVEL ALLOSTERIC MODULATOR OF THE 
GLYCINE RECEPTOR USING PHAGE DISPLAY 
 
3.1 - Introduction 
 The glycine receptor (GlyR) is a member of the Cys-loop superfamily of ligand-
gated ion channels, which also includes the γ-aminobutyric acid type A (GABAA) and 
serotonin-3 receptors (Ortells and Lunt, 1995).  GlyRs constitute the major inhibitory 
neurotransmitter receptor system in the brainstem and spinal cord, where they are thought 
to play a role in the modulation of pain signals and the effects of volatile anesthetics.  
GlyRs are also found throughout higher brain regions, including the thalamus, 
hippocampus, and nucleus accumbens, where they were recently shown to be involved in 
the reinforcing properties of ethanol (Lynch, 2004; Molander and Soderpalm, 2005).  The 
GlyR is only one of many ion channels and receptors thought to play a role in pain 
perception, the effects of alcohol and volatile anesthetics, and in determining the state of 
neuronal excitability.  The isolation of the contribution of the GlyR to these various 
functions is hindered by the fact that, to date, no potent and efficacious allosteric 
modulators that act specifically at the GlyR have been identified.   
 One method for identifying molecules that show affinity for a selected target is 
phage display (PD).  PD involves the expression of a random library of small peptides on 
the coat proteins of bacteriophage.  This approach has been used to successfully identify 
peptides that bind with high affinity to a wide variety of cellular targets.  In this thesis, I 




that modulate GlyR function without affecting two closely related GABA receptors.  I 
utilized the Ph.D.™-12 Phage Display Peptide Library (New England Biolabs), which is 
based on a combinatorial library of random dodecapeptides fused to a minor coat protein 
(pIII) of M13 phage.  The library consists of approximately 2.7 x 109 electroporated 
sequences amplified once to yield approximately 100 copies of each sequence in 10 µl of 
the supplied phage, making this a very high-throughput approach for identifying GlyR-
binding peptides.  The goal of these experiments is to develop a phage selection protocol 
that will allow for the identification of peptides that bind to the GlyR and modulate its 
function. 
 
3.2 - Materials and Methods 
 Phage selection as well as the isolation, injection, and two-electrode voltage 
clamp of Xenopus oocytes were conducted as described in Chapter 2. Specific methods 
pertaining to the experiments in this chapter are outlined below.  All chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise indicated. 
 Human Embryonic Kidney cells (HEK 293) were grown according to standard 
procedures (Freshney, 2002).  Cells were cultured at 37oC in a 5% CO2 atmosphere in 
Dulbecco’s modified Eagle’s medium with L-glutamine, sodium pyruvate, and 10% fetal 
bovine serum (Invitrogen).  Cell lines were split every 5 days with trypsin/EDTA in 
Hank’s balanced salt solution.  Cells were transfected with 8 mg of GlyR α1 subunit 




exposed to PolyFect and then split with no DNA exposure.  All cells were incubated for 
at least 48 h before use in panning. 
 Panning day 1: A plate of control cells was washed three times with 0.01 M 
phosphate-buffered saline (PBS) containing 8.2 mM NaPO4, 1.5 mM KH2PO4, 137 mM 
NaCl, and 2.7 mM KCl with 1.5% bovine serum albumin (BSA) and 0.1% Tween 
(PBS/BSA-T).  An aliquot containing 2 x 1011 phage from the D12 phage library (New 
England Biolabs) was diluted in 1 ml of PBS/BSA-T.  Phage were then applied to control 
cells and rocked gently at room temperature for 30 min. Phage that did not bind in this 
negative selection procedure were removed from the plate with a pipette, applied to a 
plate of GlyR-expressing cells (positive selection), and rocked gently at room 
temperature for 60 min.  Non-binding phage were discarded, and the plate was washed 
five times with PBS/BSA-T.  Elution of the bound phage was performed by lowering the 
pH using 0.2 M glycine HCl (10 M HCl buffered to pH 2.2 with glycine) plus 1 mg/ml 
BSA and rocking the cells at room temperature for 10 min. The eluate was removed and 
neutralized with 150 ml of 1 M Tris-HCl (pH 9.0).  Titering was performed, and the 
remainder of the eluate was added to 20 ml of Escherichia coli (A600) in LB broth. After 
4.5 h or incubation, the culture was transferred to a 50-ml Falcon centrifuge tube and 
spun at 10,000 rpm for 10 min at 4oC.  The supernatant was transferred to a fresh tube 
and respun.  The upper 80% of the supernatant was again transferred to a fresh tube and a 
one-sixth volume of polyethylene glycol/NaCl (20% w/v polyethylene glycol 8000 and 




 Panning day two: The polyethylene glycol precipitates were spun at 10,000 rpm 
for 15 min at 4oC.  The supernatant was decanted, and the precipitate was spun again.  
Residual supernatant was removed using a pipette.  The pellet was resuspended in 1 ml of 
Tris-buffered saline (50 mM Tris-HCl pH 7.5 and 150 mM NaCl), transferred to a 1.7-ml 
microcentrifuge tube, and spun at 10,000 rpm for 5 min at 4oC.  In a fresh tube, the 
suspended phage were reprecipitated with polyethylene glycol/NaCl on ice for 60 min.  
After spinning at 10,000 rpm for 10 min at 4oC, the supernatant was discarded.  The 
pellet was resuspended in Tris-buffered saline and spun again for 1 min. The supernatant 
was then transferred to a fresh tube and stored at 4oC.  Aliquots of the amplified phage 
were titered at three successive dilutions.  
 For successive panning rounds, the amplified phage were diluted in PBS/BSA-T 
so that the input concentration was always 2 x 1011 virons.  At the end of five rounds of 
panning, individual plaques from the most recent titer plates were isolated and incubated 
overnight in LB broth at 37oC with agitation.  The overnight culture was then purified 
using the S.N.A.P. MiniPrep kit (Invitrogen) and the phage DNA was sequenced in-house 
using a -96gIII sequencing primer (New England Biolabs).  Individual peptide sequences 
were sent to Peptide 2.0 Inc. (Chantilly, VA) for synthesis.  Peptides were received as 
lyophilized powders of 98% pure TFA salts and were dissolved in MBS at a 
concentration of 100 mM.  These stock peptide solutions were stored at 4oC. 
 Two high-resistance (0.5 – 10 MW) glass electrodes filled with 3 M KCl were 
used to impale the animal poles of isolated oocytes injected with either GlyR α1 or 




725C oocyte clamp (Hamden, CT), and MBS was perfused over them at a rate of 2 
ml/min using a Masterflex USA peristaltic pump (Cole Parmer Instrument Co, Vernon 
Hills, IL) through 18-gauge polyethylene tubing.  All glycine, GABA, and peptide 
solutions were prepared in MBS, and all applications (30 sec) were followed by 5 – 10 
min washout periods as appropriate.  
 Current peak responses were measured from chart recorder tracings.  Peptide 
effects were calculated as percent changes compared with the effects produced by glycine 
or GABA in the absence of peptide. In all cases, oocyte data were obtained from at least 
two different frogs.  The percent enhancement or inhibition values obtained in the 
presence of peptide were compared by either one- or two-way analysis of variance, as 
indicated, to determine statistical significance, with a criterion of p < 0.05. 
 
3.3 - Results 
 
3.3.1: Development of the Phage Display Selection Assay 
 PD selection requires that the target be purified, immobilized, and presented in the 
correct conformation.  With soluble proteins, the target is often attached to a scaffold to 
immobilize it for the selection process.  While this approach does allow for selection 
against the entire protein surface, it is not ideal for membrane-bound proteins, such as ion 
channels.  The presence of the cell membrane is crucial to the folding and subsequent 
functionality of channel proteins (Heidmann et al., 1980).  In addition, the presence or 




membrane.  Another approach is to use the isolated extracellular domain of the target 
(Kallen et al., 2000; Saggio et al., 1995); however, this is limited to targets that can be 
easily purified and correctly folded in the absence of transmembrane domains.  The ideal 
selection process for ion channel targets would involve the expression of the channel in a 
system that ensures the proteins are in the same conformation as those found in vivo.  
However, the use of cell-expressed channels, such as those found in primary neuronal 
culture, introduces a complex background of other cellular components that can hinder 
the ability to isolate phage bound to the target of interest.  Electrophysiological studies 
aimed at characterizing ion channels have often utilized the expression of the channel of 
interest in non-neuronal cell lines, such as human embryonic kidney cells (HEK) or 
Chinese hamster ovarian cells (CHO).  These cells possess the necessary machinery to 
generate functional channels and insert them into the cell membrane. We chose HEK 
cells for the expression of GlyRs in this study.  GlyRs expressed in HEK cells have been 
used in a wide variety of experimental assays.  However, HEK cells contain a variety of 
endogenous membrane components. In order to remove the phage from our library that 
bind to these components, we used a modified negative selection protocol (Oyama et al., 
2006).  The phage were first applied to a plate of HEK cells that had been treated with the 
transfecting agent in the absence of GlyR DNA (blank cells). The phage that bound to 
these cells, i.e., those carrying peptide sequences with affinity for the endogenous HEK 
membrane components, were discarded. The phage that did not bind were siphoned off 
and applied to a second plate of cells. These cells were exposed to the same transfecting 




addition to all of the membrane components found in the first plate of cells. The phage 
that bound to these cells were collected for further rounds of amplification and panning, 
as outlined in Materials and Methods.  It is important to note that this selection process 
limited the sequences collected to only those peptides that bound to the extracellular 
portion of the channel. Homomeric GlyR α1 was chosen as the target rather than 
heteromeric GlyR α1β because of its invariant stoichiometry: heteromeric α1β receptors 
contain αα, αβ, and βα intersubunit interfaces.  In addition, we wanted to avoid the 
possible complication that some receptors in our population were α1 homomers, while 
others were α1β heteromers.  After five rounds of panning, 35 individual colonies were 
sequenced to identify the peptides inserted in the phage pIII protein (Table 3.1).  Three 
sequences were harvested from multiple colonies, implying selective enrichment of our 
phage pool.  No clear amino acid sequence homology was seen among the collected 
sequences.  Due to the size of the extracellular domain of the GlyR, and thus a large 







Phage Sequence                 Frequency 
12-100 T S Y T T S I F G P R A 1 
12-101 I L A N D L T A P G P R 1 
12-104 N Y M S A L A I T T S L 1 
12-105 K P A N L T S T P W V P 1 
12-106 L L A D T T H H R P W T 1 
12-107 I S M P V R P L L Q D F 1 
12-108 S I V S T Q T S L P L N 1 
12-109 S M T S H N Q W H L L A 1 
12-110 A N P S P S T H H L T P 1 
12-111 T T T L L T A T P H P H 1 
12-112 Y P S F T H S A T P S L 1 
12-113 F H Q N S L R V H S S P 1 
12-114 Q D V H L T Q Q S R Y T 1 
12-115 N L N H E R S Q N L K M 1 
12-116 Y E S I R I G V A P S Q 1 
12-117 E R V M L P F P P A P W 2 
12-119 I P W T Q H M A M S P M 1 
12-120 T N T S W M T A M T P F 1 
12-121 T H T T N A E G Y S P V 1 
12-122 T M G F T A P R F P H Y 1 
12-124 S V S V G M K P S P R P 4 
12-123 S I N G Q W M R A I G K 1 
12-125 G I Q L A N P P R L Y G 1 
12-127 Q D M L K P Y V D P L H 1 
12-128 S H H I P S Y Q W P L H 1 
12-130 W A E T W P L A Q R P P 1 
12-131 S N Q T S D R P P L L T 1 
12-133 S S L E P W H R T T S R 2 
12-136 E W L A Y D G I R A Y S 1 
12-138 E T L P I T L I A R L T 1 
	  
Table 3.1:  Sequences of peptides identified by panning against α1 GlyR 
 
A total of 35 sequences were collected following five rounds of panning.  Frequency refers to the 
number of times a particular sequence was collected. The diversity of the peptide sequences was 




3.3.2: Functional Characterization of Selected Peptides 
Ten peptide sequences were chosen from this list to be tested for their ability to 
modulate GlyR function.  Two-electrode voltage clamp in Xenopus oocytes was used to 
characterize the functional effects of these peptides on homomeric GlyRs. A maximally 
effective concentration of glycine (10 mM) was first applied to determine the level of 
GlyR expression.  This maximal response was used to determine a low concentration of 
glycine that elicited a response equal to ~10% of the maximal current (EC10, where EC is 
the effective concentration).  The EC10 was applied several times to ensure a stable 
baseline glycine response.  The oocyte was then incubated with 30 mM of a peptide for 
30 s, followed by co-application of the peptide and EC10 glycine.  Peptides that did not 
show a significant effect at this concentration were not tested further.  This does not rule 
out the possibility that effects might be seen at higher concentrations; however, peptides 
requiring more than 30 mM would not be as useful as those that were more potent.  None 
of the peptides tested had any effect in the absence of glycine.  This implies that they 
neither function as agonists at the glycine-binding site nor affect the function of any other 
naturally-occurring oocyte proteins that might influence the holding current.  Some 
peptides, such as D12-106, inhibited the effect of glycine (Figure 3.1A), while others, 
such as D12-105, enhanced the glycine effect (Figure 3.1B).  The ten peptides tested 
exhibited a variety of effects on GlyR function, ranging from 65% inhibition to 124% 







Figure 3.1 – Identification of peptides acting as allosteric modulators at the GlyR 
 
(A, B) Representative tracings showing the effects of a 30 µM concentration of peptide D12-106 (A) and 
D12-105 (B) on the currents elicited by EC10  glycine.  Neither peptide had any effect in the absence of 
glycine. When co-applied with glycine, D12-106 inhibited the effect of EC10 glycine (A), while D12-
105 potentiated GlyR function (B).  (C) Percent changes in EC10 glycine responses produced by co-
application with 30 µM of D12 peptides following a 30 s application of peptide alone.  These peptides 
exhibited varying degrees of potentiation or inhibition at the GlyR, but none acted as agonists by 





3.3.3: Test for Specificity using GABAA/C Receptors 
Although the peptides were chosen based on their abilities to bind to the GlyR, 
there was a chance that they might also affect other structurally related channels.  The 
members of the Cys-loop receptor superfamily possess considerable structural and amino 
acid sequence homology (Ortells and Lunt, 1995).  The GlyR is most similar to the other 
anion-conducting channels in this family.  Of these, the GABAC, previously referred to as 
GABA ρ1, subunit is the most similar to the GlyR α1, with ~60% amino acid sequence 
identity, followed by the other members of the GABAA group (Grenningloh et al., 
1987a).  To test the specificity of our peptides, we compared the functional effects on the 
GlyR α1 receptors with those on homomeric GABA ρ1 and heteromeric α1β2γ2 GABA 
channels.  Although many types of GABAA receptors exist, those composed of α1, β2, 
and γ2 subunits are the most widely expressed in the adult mammalian nervous system, 
making them the most important for possible cross-over effects.  As with the GlyR 
experiments, oocytes expressing GABA channels were tested for maximal GABA 
responses, and an EC10 GABA concentration was determined.  The peptides were then 
applied using the same pre-application protocol.  Figure 3.2 (A and B) shows sample 
tracings of the effects of peptides D12-106 and D12-133 on GABA responses in the 
a1b2g2 channels. D12-106 produced a minor inhibition of the GABA response, while 
D12-133 had almost no effect on these channels.  The data presented in Figure 3C have 
been scaled to match those presented in Figure 2C in order to illustrate that the peptide 




with the GlyR tests, none of the peptides had any effect in the absence of GABA or 







Figure 3.2 – Minimal effects of peptides as allosteric modulators at the GABAA receptor 
 
(A, B) Representative tracings showing the effects of a 30 µM concentration of peptide D12-106 (A) and 
D12-133 (B) on GABAA α1β2γ2 receptor function.  Neither peptide had any effect when applied in the 
absence of GABA. (A) D12-106 showed a small inhibition of the GABA effect when co-applied with 
GABA following a 30 s application of peptide alone.  (B) D12-133 had no effect when co-applied with 
GABA or when applied alone for 30 s.  (C) Percent changes in responses to EC10 GABA produced by 30 
µM concentrations of D12 peptides pre-applied for 30 s, followed by co-application with GABA for 30 s.  
None of the peptides acted as agonists by directly activating the receptor and had minimal to no effects in 




3.3.4: Specificity of Peptide D12-116 
Peptide D12-116 produced a marked enhancement of GlyR function (t = 5.783, p 
< 0.001) but did not affect GABAA/C responses (GABAA: t = -0.862, p = 0.428; GABA 
r1: t=1.00, p=0.391). This peptide was next assayed with a more stringent specificity test 
using GABA ρ1 homomeric receptors.  Figure 3.3 (A-D) compares the effect of this 
peptide at 30 µM on the EC10 responses of both GABA channels. Even at 100 µM of 
peptide, D12-116 showed no effects on either GABA channel, implying that this effect is 
due to true specificity, rather than to potential differences in peptide potency among the 
receptor types.  This lack of effect on the channels most structurally similar to the GlyR 
makes it unlikely that this peptide would have non-specific effects on other, more 






Figure 3.3 – Peptide D12-116 demonstrates specificity for the GlyR 
 
(A - C) Representative tracings of the effect of 30 µM D12-116 on the response elicited by EC10 glycine 
on α1 GlyR (A) and EC10 GABA on GABAA α1β2γ2 (B) and GABA ρ1 (C) receptors.  (A) D12-116 
produced significant enhancement of GlyR α1 function when co-applied with glycine following a 30 s 
application of peptide alone.  The same concentration of peptide had no effect on the function of either 
GABAA α1β2γ2 (B) or GABA ρ1 (C) receptors when co-applied with GABA following a 30 s application 
of peptide alone.  (D) Bar graph summarizing the effect of 30 µM D12-116 or the GlyR and two related 
GABA receptors.  D12-116 robustly potentiated the glycine response, but had no effects on either GABA 
receptor.  A one-way analysis of variance showed a significant difference in peptide responses among 




3.3.5: Characterization of Peptide D12-116 
A concentration-response curve was generated using the D12-116 peptide (Figure 
3.4A). When co-applied with EC10 glycine, the threshold concentration required to elicit 
the enhancing effect of D12-116 was ~3 µM, and the maximal response occurred at 40 
µM peptide. Higher concentrations were less efficacious, resulting in a bell-shaped curve. 
This could imply that this peptide forms aggregates at higher concentrations or that 
multiple binding sites with different affinities for the peptide exist on the GlyR. Next 
glycine concentration-response curves were plotted in the presence and absence of 30 µM 
D12-116. The peptide significantly left-shifted the glycine curve [F(1,63) = 130, p < 
0.001] without affecting the response to saturating glycine (Figure 3.4B). This result 
suggests that this peptide acts as a positive allosteric modulator of the GlyR, much like 
alcohols and volatile anesthetics, which also left-shift the glycine concentration-response 





















Figure 3.4 – Characterization curves of peptide D12-116 
 
(A) Percent change in the response elicited by EC10 glycine co-applied with various concentrations of 
D12-116 peptide.  Oocytes were incubated with 1 – 100 µM of D12-116 for 30 s followed by a co-
application of peptide with glycine.  None of the peptide concentrations tested elicited currents in the 
absence of glycine.  The threshold peptide concentration for GlyR enhancement is between 3 and 10 µM.  
(B) D12-116 acts as an allosteric modulator of GlyR function by shifting the glycine concentration-
response curve to the left. Concentrations of glycine (1 – 10,000 µM) were co-applied with 30 µM D12-
116. (○) glycine applied alone. (●) glycine plus 30 µM D12-116.  Curves were fit using a four-parameter 
logistic equation.  The EC50 of the glycine curve was 796 µM, which was decreased to 196 µM in the 
presence of peptide.  Two-way analysis of variance showed significant effects of glycine concentration 
[F(7,63) = 505, p < 0.001] as well as the presence of peptide [F(1,63) = 130, p <0.001].  Data are 




3.3.6: Alanine Scan of Peptide D12-116 
When investigating protein-protein interactions, an alanine scan is often used to 
identify important residues (Wells, 1991; Cunningham and Wells, 1989).  In this 
approach, each amino acid is individually replaced with an alanine residue, which is 
small and uncharged.  Substitution with an alanine removes all side chain atoms past the 
b-carbon, thus individual alanine mutations can be used to infer the roles of individual 
side chains.  Eleven mutants of D12-116 in which a single amino acid had been replaced 
with an alanine residue (D12-116 1A-12A) were generated.  Residue 9, which is an 
alanine in the original sequence, was not mutated for this screen.  While the majority of 
these modified peptides did not show significantly different effects from the original 
D12-116 (Figure 3.5), two mutations caused significant changes in the response to 30 
µM peptide. Replacement of the glutamine residue at position 12 significantly reduced 
the effect of this peptide (t=2.19, p < 0.05).  In addition, the replacement of the isoleucine 









Figure 3.5 – Alanine scan of peptide D12-116 (Y E S I R I G V A P S Q) 
  
Illustration of percent changes in the EC10 glycine responses when single amino acid alanine mutants 
of  peptide D12-116 were co-applied with 30 µM peptide.  Each residue along the D12-116 peptide 
was individually replaced with an alanine residue with the exception of residue 9, which is an alanine 
in the original sequence.  The grey line marks the mean peptide enhancement of the original D12-116 
peptide (the left-most bar).   The degree of enhancement of the EC10 glycine response was 
significantly increased for peptide 116-A6 (YESIRAGVAPSQ; p < 0.005) and was significantly 




3.3.7: Effect of Peptide D12-116 on Different GlyR Subtypes 
 In mammalian systems, the α1, α2, and α3 GlyR subunits are expressed 
throughout the CNS (Lynch, 2009). These subunits have shown differential effects to 
several GlyR modulators, including ethanol. Thus, we compared the effects of 30 µM 
D12-116 on homomeric α1, α2, and α3 GlyRs.  While this peptide robustly potentiates 
α1 receptors, α2 receptors showed only a weak potentiating response and α3 receptors 
were inhibited (Figure 3.6).  GlyRs containing α2 subunits have reduced responses to the 
enhancing effects of several modulators (Lynch, 2009), thus the reduced response to 116 
is unsurprising.  However, the inhibitory response of the α3 homomeric channels is 
striking. The α1 and α3 subunits are more similar in sequence than the α1 and α2 
subunits, particularly in the extracellular domain.  These data reinforce the idea that these 







Figure 3.6 – Peptide D12-116 has differential effects on GlyR α subtypes 
 
Percent change in EC10 glycine response observed after co-application of glycine with D12-116 at GlyR 
α1, α2 and α3 homomeric receptors.  The peptide robustly potentiated the glycine effect on Gly α1 
receptors. The potentiating effect on Gly α2 receptors was reduced compared to α1 receptors.  On Gly 






          One of the most pharmacologically relevant roles proposed for the GlyR in vivo is 
the mediation of some alcohol-induced behaviors.  Many cell-surface proteins, including 
voltage- and ligand gated ion channels, enzymes, and transporters, are thought to play a 
role in the effects of ethanol.  However, the relative importance of each individual 
putative target to the effects of alcohol in vivo remains poorly understood (Vengeliene et 
al., 2008).  This deficit has been a major impediment to the rational identification of 
compounds to treat alcohol abuse.  The enhancement of inhibitory GlyRs by ethanol is 
consistent with some of the behavioral consequences of alcohol consumption (Molander 
and Soderpalm, 2005; Ye et al., 2009).  However, because ethanol clearly affects multiple 
biochemical targets in addition to the GlyR, it has proved difficult to determine 
conclusively the roles that individual putative targets play in the various behavioral 
effects of this agent.  There would thus be great utility in identifying compounds that can 
act as either ethanol mimics or ethanol antagonists at only one putative alcohol target.  
For example, if we were to administer peptide D12-116, which enhanced GlyR function 
similar to ethanol, intrathecally to rats and observe ataxia, it would suggest that the ataxia 
produced by ethanol is also mediated by the enhancement of GlyR function.   
 Although studies using knock-out and knock-in mice (Crabbe et al., 2006) have 
provided some successes with regard to isolating the effects of individual ethanol targets, 
these methods, due to their nature, involve a departure from the wild-type phenotype.  An 
alternative approach is the highly specific pharmacological manipulation of individual 




rather than complete removal or blockade.  Our identification of a GlyR-specific 
enhancing peptide allows for the emulation of the effects of ethanol at just this one site.  
The identification of agents that modulate or mimic the actions of ethanol or volatile 
anesthetics at targets with high specificity could allow for the determination of the 
contributions of those sites to the overall effects of these compounds without altering the 
wild-type baseline GlyR function.  A better understanding of the relative importance of 
individual targets could also lead to the development of more targeted therapeutics.  
There are many instances of small molecules acting as specific allosteric 
modulators of proteins (Berg, 2003; May et al., 2004).  For example, benzodiazepines 
bind at nanomolar concentrations to GABAA receptors composed of specific subunits.  
They can act as agonists, inverse agonists, or antagonists at a site distinct from the 
GABA-binding site. These compounds modulate the GABA-mediated currents, but have 
no effects when applied alone (Mihic et al., 1994).  In addition, a number of small 
molecules, peptides, and modified peptides are known to have substantial effects on 
neurophysiology, such as enkephalins and conotoxins. Peptides that modulate the 
function of putative ethanol targets have also been identified (Wilkemeyer et al., 2002; 
Guzman et al., 2009).  For example, the octapeptide NAPVSIPQ antagonizes ethanol 
inhibition of L1-mediated cell adhesion and is protective against ethanol-induced 
embryotoxicity (Wilkemeyer et al., 2003).  
Previous work used phage display to identify novel peptides that demonstrated 
high affinities for selected ion channels and acted as either agonists or antagonists at their 




have also been used to identify an antagonist of the N-methyl-D-aspartate receptor (Li et 
al., 1996).  In recent years, there has been increasing interest in the development of novel 
therapeutics that act at allosteric sites rather than acting as agonists or antagonists at the 
orthosteric ligand-binding site.  The hypothesis driving these experiments was that 
commercially available phage display technology could be used to identify specific 
allosteric modulators acting to either enhance or inhibit GlyR function, i.e., compounds 
that left- or right-shift glycine concentration-response curves while having no effects on 
their own.  The peptides we identified acted as allosteric agonists to enhance glycine 
effects (D12-116) or as inverse agonists that reduced glycine effects (D12-106).   
Our approach utilizes the cellular expression of the target protein rather than 
scaffolding the purified target.  This allows for selection in the native environment of the 
target and minimizes concerns about misfolding of the target protein.  As a result, our 
peptides have the opportunity to bind only in the extracellular region of the channel.  
Because none of the peptides tested thus far acted as agonists when applied alone, 
peptides of this size may not be able to bind at the intersubunit orthosteric glycine-
binding site (Lynch, 2004) to directly activate the GlyR.  In the positive selection portion 
of the phage display screen, we expressed the GlyR in HEK 293 cells in the absence of 
exogenously added glycine, so we assume that selection occurred against GlyRs in the 
closed state.  However, glycine is a component in the media in which the HEK cells were 
grown.  While this media was washed away prior to the selection process, it is important 




circumvent possible concerns about cell type-specific binding, we used receptors 
expressed in Xenopus oocytes for the functional tests.  
The diversity of peptides identified in our panning screen suggests that a more 
stringent negative control during phage panning might increase peptide specificity.  For 
example, expressing one or both of the GABAA/C receptor subtypes tested here in the 
negative selection portion of the panning procedure would be expected to remove those 
peptides that bind to both GABA and GlyRs, such as D12-106 and D12-124.  Another 
possibility would be to identify peptides that bind only to specific GlyR subunits by 
expressing GlyR α2 and/or α3 subunits in the negative selection and α1 subunits in the 
positive selection.  The data for 116 suggests that these receptor subtypes can be 
differentially modulated by peptides, thus this approach could be utilized to address the 
lack of subunit specific GlyR modulators. 
While a high number of isolated peptide sequences with very little sequence 
homology often implies that the selection process was unsuccessful, each of the ten 
peptides tested for function modulated the GlyR to some degree (Figure 3.1).  In addition 
to validating the selection process, this also suggests that the GlyR contains several 
potential binding sites in the ECD.  Identifying the binding sites for these peptides could 
lead to the discovery of novel “drugable” sites on the GlyR.  The specificity of D12-116 
implies that at least one of these binding sites may be unique to the GlyR. 
The alanine scan data highlights the utility of phage-derived peptides as 
pharmacological leads.  That is, the original peptide can be systematically adjusted to 




Mutation A6, in which the isoleucine at position 6 is replaced with an alanine, 
significantly enhanced the effect of this peptide.  If this version of the peptide maintains 
specificity for the GlyR, it may be a more useful tool for GlyR characterization than the 
original 116.  This approach also provides information regarding the characteristics of the 
peptide that are critical for the functional effects. For example, replacing the glutamine at 
position 12 with a non-polar alanine residue significantly reduced the potentiating effect 
of this peptide.  The location of this residue makes it unlikely that this loss of effect is 
due to a major change in the folding of the peptide, suggesting instead that the glutamine 
is important for the interaction of the peptide with the GlyR.  In addition to providing 
important functional information regarding the peptide:channel interaction, the alanine 
scan also revealed residues that are important or other peptide features, such as solubility.  
The removal of the proline residue at position 10 greatly decreased the solubility of the 
peptide in MBS.  The stock solution for this peptide was kept at 50 µM because the 
peptide precipitated out of solution at higher concentrations. 
In summary, by pairing a high throughput peptide screen with a standard 
electrophysiological test, we identified and characterized novel specific peptide allosteric 
modulators of the GlyR.  Other approaches to rapidly identify channel modulators have 
been developed (Gilbert et al., 2009); however, our method is easily transferable to other 
channel targets and has minimal set-up requirements.  This approach could be modified 
for almost any target expressed in an adhering cell system and is particularly useful for 





4.0 | IDENTIFICATION OF PEPTIDES WITH SUBUNIT SPECIFIC EFFECTS 
 
4.1 - Introduction 
There are five known GlyR subunits: α1-4 and β. These channels are pentameric in 
structure and can be formed of either five a subunits (homomeric) or two α and three β 
subunits (heteromeric) (Lynch, 2004).  There is some experimental evidence that 
different α subunits can form heteromeric receptors; however, the existence of such 
channels has not been reported in vivo (Kuhse et al., 1993).  Prenatally, α2 homomeric 
receptors are the dominant form of GlyR.  After birth, there is a developmental shift to 
α1β receptors that continues until the third postnatal week (Becker et al., 1988).  
While GlyRs containing α1 and β subunits are the most abundant in the adult system, 
recent reports have identified α2- and α3-containing receptors in several regions of the 
CNS, often with distinct cellular and regional localizations.  For example, several groups 
have reported extrasynaptic α1, α2 and α3 homomeric receptors in various brain regions. 
These receptors are primarily located on presynaptic cells and are thought to be involved 
in modulating the release of glutamate, glycine, and GABA (Turecek and Trussell, 2001; 
Jeong et al., 2003; Ye et al., 2004).  Recently, the expression of α3β GlyR receptors has 
been reported in the hippocampus (Meier et al., 2005) and nociceptive neurons in the 
laminae I and II of the spinal cord dorsal horn (Harvey et al., 2004), where they play an 
important role in inflammatory pain responses (Ahmadi et al., 2002). 
The different channel subtypes have distinct kinetic properties, including a slower 




conductance in β-containing heteromers (Lynch, 2009).  In addition, there is some 
evidence that the expression of these subtypes may be highly localized.  For example, in 
the retina, different a subunits were found to be associated with specific types of cells 
(Ivanova et al., 2006).  This highly defined localization paired with differing sensitivities 
to pharmacological agents suggests that individual subtypes may be tailored for specific 
purposes within the CNS.  
To date, there is no pharmacological agent that can differentiate between the different 
α subunits. Although many compounds exhibit modest subunit-specific differences, none 
of them can fully discriminate between α1-, α2-, and α3-containing subunits in either 
homomeric or heteromeric channels.  Those compounds that do show some 
discrimination among the channel types, such as picrotoxin, often have potent effects on 
other receptor families, which limits their utility (Lynch, 2009).  Subtype specific 
compounds would be useful for differentiating between subtypes in vitro and could lead 
to the development of novel treatments for inflammatory pain and movement disorders.  
The subunit differences exhibited by the D12-116 peptide (Figure 3.6) led to the 
hypothesis that phage display could be used to identify peptides that discriminate 
between different α subunits.  The panning procedure was modified to include GlyR α2β 
and α3β channels in the negative selection in order to identify peptides that specifically 
modulate α1β receptors.  This approach yielded several promising peptides, suggesting 






4.2 - Materials and Methods 
Phage selection, site directed mutagenesis and the isolation, injection, and two-
electrode voltage clamp of Xenopus oocytes were conducted as described in Chapter 2. 
Specific methods pertaining to the experiments in this chapter are outlined below.  All 
chemicals were obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise 
indicated. 
 Human Embryonic Kidney cells (HEK 293) were grown according to standard 
procedures (Freshney, 2002).  Cells were cultured at 37oC in a 5% CO2 atmosphere in 
Dulbecco’s modified Eagle’s medium with L-glutamine, sodium pyruvate, and 10% fetal 
bovine serum (Invitrogen).  Cell lines were split every 5 days with trypsin/EDTA in 
Hank’s balanced salt solution.  Cells were transfected with a total of 8 mg cDNA (1:10 
α:β) using Lipofectamine2000 reagent (Invitrogen). All cells were incubated for at least 
48 h before use in panning. 
 Panning day 1: A plate of negative selection cells (expressing either a2b or a3b 
GlyRs) was washed three times with 0.01 M phosphate-buffered saline (PBS) containing 
8.2 mM NaPO4, 1.5 mM KH2PO4, 137 mM NaCl, and 2.7 mM KCl with 1.5% bovine 
serum albumin (BSA) and 0.1% Tween (PBS/BSA + T).  An aliquot containing 2 x 1011 
phage from the D12 phage library (New England Biolabs) was diluted in 1 ml of 
PBS/BSA -T.  Phage were then applied to negative selection cells (α2β or α3β) and 
rocked gently at room temperature for 30 min. Phage that did not bind in this negative 
selection procedure were removed from the plate with a pipette, and transferred to the 




the negative control cells were presented was alternated for each selection round.  Phage 
that did not bind in the second negative control were removed using a pipette, applied to 
a plate of α1β GlyR-expressing cells (positive selection), and rocked gently at room 
temperature for 60 min.  Non-binding phage were discarded, and the plate was washed 
five times with PBS/BSA-T.  Elution of the bound phage was performed by lowering the 
pH using 0.2 M glycine HCl (10 M HCl buffered to pH 2.2 with glycine) plus 1 mg/ml 
BSA and rocking the cells at room temperature for 10 min. The eluate was removed and 
neutralized with 150 ml of 1 M Tris-HCl (pH 9.0).  Titering was performed, and the 
remainder of the eluate was added to 20 ml of E. coli (A600) in LB broth. After 4.5 h or 
incubation, the culture was transferred to a 50-ml Falcon centrifuge tube and spun at 
10,000 rpm for 10 min at 4oC.  The supernatant was transferred to a fresh tube and 
respun.  The upper 80% of the supernatant was again transferred to a fresh tube and a 
one-sixth volume of polyethylene glycol/NaCl (20% w/v polyethylene glycol 8000 and 
2.5 M NaCl) was added. Phage were allowed to precipitate overnight at 4oC.  
 Panning day two: The polyethylene glycol precipitates were spun at 10,000 rpm 
for 15 min at 4oC.  The supernatant was decanted, and the precipitate was spun again.  
Residual supernatant was removed using a pipette.  The pellet was resuspended in 1 ml of 
Tris-buffered saline (50 mM Tris-HCl pH 7.5 and 150 mM NaCl), transferred to a 1.7-ml 
microcentrifuge tube, and spun at 10,000 rpm for 5 min at 4oC.  In a fresh tube, the 
suspended phage were reprecipitated with polyethylene glycol/NaCl on ice for 60 min.  
After spinning at 10,000 rpm for 10 min at 4oC, the supernatant was discarded.  The 




was then transferred to a fresh tube and stored at 4oC.  Aliquots of the amplified phage 
were titered at three serial dilutions.  
 For successive panning rounds, the amplified phage were diluted in PBS/BSA-T 
so that the input concentration was always 2 x 1011 virons.  At the end of five rounds of 
panning, individual plaques from the most recent titer plates were isolated and incubated 
overnight in LB broth at 37oC with agitation.  The overnight culture was then purified 
using the S.N.A.P. MiniPrep kit (Invitrogen) and the phage DNA was sequenced in-house 
using a -96gIII sequencing primer (New England Biolabs).  Individual peptide sequences 
were sent to Peptide 2.0 Inc. (Chantilly, VA) for synthesis. Peptides were received as 
lyophilized powders of TFA salts.  The peptides were dissolved in MBS at a 
concentration of 200 µM and stored at 4oC. 
 Custom oligonucleotide primers were designed using the NetPrimer primer design 
program (Premier Biosoft) and obtained from Integrated DNA Technologies (Coralville, 
IA).  The following primers were used to generate the mutations: Group 1 – F: GAG 
GCT GAA GCT GCT CGC TCC CGA TCC GCG CCT ATG TCA CCC TCG GAT 
TTC CTG, R: CAG GAA ATC CGA GGG TGA CAT AGG CGC GGA TCG GGA 
GCG AGC AGC TTC AGC CTC; Group 2 – F: GAC CTC ATC TTT GAG TGG CAG 
GAT GAG GCA CCC GTG CAG GTA GCA GAT GGA CGA ACT CTG, R – CAG 
AGT TAG TCC ATC TGC TAC CTG CAC GGG TGC CTC ATC CTG CCA CTC 
AAA GAT GAG GTC; S121F – F: GAC AAC AAA TTG CTA AGG ATC TTC CGG, 
R: CCG GAA GAT CCT TAG CCA TTT GTT GTC; A212V – F: GGT AAA TTC ACC 




GCA GGT GAA TTT ACC.  All mutants were made using the a1 GlyR cDNA as the 
template and the Stratagene (Cedar Creek, TX) QuickChange Mutagenesis Kit.  The 
forward and reverse primers (125 ng/ml) were individually combined with the template 
a1 cDNA (25 ng/ml), nucleotide triphosphates, and Taq DNA polymerase and run 
through the first 15 cycles of a linear amplification thermocycling protocol in a PTC-100 
thermocycler.   The forward and reverse mixtures were then combined 1:1 and run 
together for another 15 cycles.   
Two high-resistance (0.5 – 10 MW) glass electrodes filled with 3 M KCl were 
used to impale the animal poles of isolated oocytes injected with  
GlyR cDNA (1:20 a:b).  Cells were voltage-clamped at -70 mV using a Warner 
Instruments OC-725C oocyte clamp (Hamden, CT), and MBS was perfused over them at 
a rate of 2 ml/min using a Masterflex USA peristaltic pump (Cole Parmer Instrument Co, 
Vernon Hills, IL) through 18-gauge polyethylene tubing.  All peptide solutions were 
prepared in MBS, and all applications (30 sec) were followed by 5 – 10 min washout 
periods as appropriate.  
 Current peak responses were measured from chart recorder tracings.  Peptide 
effects were calculated as percent changes compared with the effects produced by glycine 
in the absence of peptide.  In all cases, oocyte data were obtained from at least two 
different frogs.  The percent enhancement or inhibition values obtained in the presence of  
peptide were compared by either t-test or one- or two-way analysis of variance, as 





4.3 - Results 
 
4.3.1: Peptides Isolated from Phage Panning 
 For these experiments I chose to use αβ heteromeric receptors rather than α 
homomers, as these are the dominant form found in the adult nervous system.  It should 
be noted that while the α1, α2, and β subunits were cloned from human DNA, the α3 
receptors used here were cloned from rat DNA.  However, the GlyR family is highly 
conserved across several mammalian species, and the human α3 subunit only differs 
from the rat α3 subunit by four amino acids, only one of which is in the extracellular 
portion of the channel (Hirata et al., 2009).  Thus, it is unlikely that the use of rat α3 in 
the negative selection procedure significantly influenced the affinities of the selected 
peptides.  The Ph.D.-7™ phage display library (New England Biolabs) was used for the 
selection process. This library is based on a combinatorial library of random 
heptapeptides fused to the N-terminus of the pIII phage coat protein.  According to the 
manufacturer, this library contains approximately 2.8 x 109 electroporated sequences with 
approximately 70 copies of each sequence per 10 µl of phage.  Following seven rounds of 
phage selection and amplification, 25 colonies were isolated and sent for sequencing.  
Similar to the original D12 panning, several different sequences were obtained.  No clear  
regions of homology were identified between the different collected sequences (Table 
4.1).  Given the stringency of the panning, this was somewhat surprising.  However, the 





Phage Sequence           
D7.2-012 S I R L D S Q 
D7.2-013 H A P K S D T 
D7.2-014 D R M P H Y F 
D7.2-015 S T F T K S P 
D7.2-016 T G A D L N T 
D7.2-017 Y T M P G E L 
D7.2-018 V I P H V L S 
D7.2-019 G V Q I M G R 
D7.2-110 N A N A A L P 
D7.2-111 S W Q Q G P Y 
D7.2-111B S T I H G S T 
D7.2-112 G S S C C K T 
D7.2-113 S I L P Y P Y 
D7.2-115 K L P G W S G 
D7.2-116 N Q L T T L N 
D7.2-118 A A P T V P R 
D7.2-119 Q E T R A P G 
D7.2-120 N Q L P L H A 
D7.2-121 G P M L A R G 
D7.2-122 T T M P I D S 
D7.2-123 T T P T K S A 
D7.2-124 V Q T Y A R G 
D7.2-125 T S L N R Y P 
D7.2-126 S H T A P L R 
D7.2-128 D V P V P Q V 
	  
Table 4.1:  Sequences of peptides identified by panning against α1β  GlyR 
 
A total of 25 sequences were collected following seven rounds of panning.  Each sequence was seen 




4.3.2: Functional Analysis of Selected Peptides 
Two-electrode voltage clamp electrophysiology in Xenopus oocytes was used 
to characterize the functional effects of these peptides on α1β GlyRs.  A maximally 
effective concentration of glycine (10 mM) was first applied to determine the level of 
GlyR expression.  This maximal response was used to determine a low concentration of 
glycine that elicited a response equal to ~10% of the maximal current (EC10, where EC is 
the effective concentration).  The EC10 was applied several times to ensure stable baseline 
glycine responses.  The oocyte was then incubated with 30 µM of a peptide for 30 s, 
followed by a 30 s co-application of the peptide and EC10 glycine.  None of the tested 
peptides had any effect in the absence of glycine.  This implies that they neither function 
as agonists at the glycine-binding site nor do they affect the functioning of any other 
naturally occurring oocyte proteins that might influence the holding current.  A variety of 
modulatory effects, ranging from 103% potentiation to 25% inhibition, were seen across 
the different peptides (Figure 4.1), confirming that these peptides were selected for their 





Figure 4.1 – Identification of D7 peptides that allosterically modulate Gly α1β  receptor function 
 
Bar graph representing the percent change in the response to EC10 glycine when co-applied with 30 µM 
concentrations of various D7 peptides.  None of the peptides showed any effects on holding currents 





4.3.3: Specificity of Isolated Peptides 
The peptides were next tested for their functional effects on the other GlyR α 
subtypes.  I hypothesized that the inclusion of α2β and α3β in the negative selection of 
the panning procedure would bias the selection towards peptides with affinity for α1-
containing receptors.  After establishing an EC10, the oocyte was incubated with 30 µM 
of a peptide for 30 s, followed by co-application of the peptide and EC10 glycine.  A 
comparison of the responses to 30 µM peptide on all three receptor subtypes is shown in 
Figure 4.2.  Most of the peptides displayed a clear reduction in effect at the α2-
containing receptors compared to the α1-containing receptors.  The selection against α3 
binding was slightly less successful, as most of the isolated peptides modulated α3-
containing receptors.  However, the α1 and α3 GlyR subunits are 98% homologous in the 
ECD.  Thus, that phase of the phage selection was very stringent, and it is unsurprising 
that many of the peptides also recognize α3-containing receptors.   Three of the tested 
peptides, D7.2-014, D7.2-111, and D7.2-128 showed significant selectivity for α1β 
GlyRs over the α2β and α3β receptors [D7.2-014: F(2,10) = 4.789, p < 0.05; D7.2-111: 







Figure 4.2 – Differential effects of D7 peptides on GlyR subtypes 
 
Effects of 30 µM D7 peptides on the EC10 glycine responses of α1β (black bar), α2β (red bar) 
and α3β (green bar) GlyR.  None of the peptides had any effect on any channel subtype when 
applied in the absence of glycine.  As described in detail in the text, the peptides varied in their 





4.3.4: Effects of GlyR α1 Mutations 
While several of our peptides show a clear preference for α1-containing receptors 
over α2- and α3-containing receptors, it is unclear if this difference is due to a reduced 
affinity for these subtypes or a difference in how the binding signal is integrated by the 
different channel subtypes.  In order to identify extracellular residues that are critical for 
these peptide differences, we generated α1 GlyR subunits containing mutations at the 
residues that differ from α3. (Figure 4.3).  As several of the differences between the 
subunits occur in clusters, two major group mutations were made. Group 3.1 included 
three mutations (A4R, P5S, and K6A), and group 3.2 included four mutations (E172D, 
Q173E, G174A, and A175P).  Two single point mutations, S121F and A212V, were also 
generated.  If the difference in peptide effect is due to binding at a non-conserved 
location, mutating these residues should prevent the peptide effect.  The effects of 30 µM 
D7.2-014 on the EC10 glycine response in these mutants were recorded and compared to 
that of wild-type α1β.   While none of the mutations fully abolished the peptide effect, 
the group 3.1 mutation reduced the peptide effect without altering the sensitivity to 

























Figure 4.3: Sequence alignment of the ECD of human GlyR α1 and rat GlyR α3 
 
Residues that differ between the hGlyR α1 and rGlyR α3 are highlighted.  The mutations 
generated for these experiments are highlighted in yellow, while all other differences are 
highlighted in blue.  The α3 subunit contains six additional residues at the beginning of  the 
sequence that do not appear in the α1 subunit.  For the purposes of this alignment, those 
residues are not listed.  Sequences were obtained from the National Center for Biotechnology 






Figure 4.4 – Group mutation 3.1 reduces the effect of peptide D7.2-014 
 
Percent change in EC10 glycine response observed after co-applying glycine with 30 µM D7.2-014.  D7.2-
014 robustly potentiated Gly α1β channels, while showing only a slight potentiation of α2β channels and a 
slight inhibition of α3β channels.  Mutating three residues in the α1 subunit to their counterparts in the α3 
subunit (A4R, P5S, K6A; group mutation 3.1) greatly reduced the potentiating effect of D7.2-014.	  Data are 




4.3.5: Characterization of Peptides 
 Concentration response curves were generated for several peptides in order to 
determine their range of effectiveness.  Various peptide concentrations were applied to 
stable EC10 glycine responses in α1β GlyRs.  Rather than the expected sigmoidal or bell-
shaped concentration response curves, most of the peptides exhibited bimodal curves, 
with a sharp peak in the low micromolar range, followed by a decrease and subsequent 
reappearance of the effect at higher concentrations.  Other peptides had inhibitory effects 
at low concentrations, but potentiating effects at higher concentrations (Figure 4.5).  The 
occurrence of these atypical curves for several peptides across several batches of eggs 
suggests that these effects are a true phenomena and not simply random occurrences.  









Figure 4.5 – D7 peptides display atypical concentration-response curves 
 
Concentration-response curves obtained from two D7 peptides.  (A) Percent change in the EC10 
glycine response when glycine was co-applied with 0.01 – 30 µM of D7.2-111.  D7.2-111 shows an 
enhancing effect of the glycine response at a concentration of 1 µM peptide and this quickly drops 
off at 10 µM, followed by a rebound in effect at 30 µM.  (B) Percent change in EC10 glycine 
response when glycine was co-applied with 0.01 – 100 µM of D7.2-017.  This peptide was 
inhibitory at low concentrations, but then produced a potentiating effect above 30 µM.  Data are 





4.4 - Discussion 
 The discovery of α2- and α3-containing GlyRs throughout the CNS has prompted 
a shift in the general assumptions about the roles of the various GlyR subtypes.  Although 
the four known α subtypes share high sequence homology, they have differing 
pharmacological properties and CNS distributions, which could have significant 
implications for GlyR-influenced behaviors.  The idea that channels composed of 
differing subtypes could have significantly different roles in the CNS is in line with data 
from other Cys-loop receptors.  For example, GABAA receptors, the other anionic 
member of the Cys-loop family, have widely varying pharmacological properties and 
suggested roles depending on their subunit composition.  Within this family, GABAARs 
containing α2 subunits are responsible for the anxiolytic effects of benzodiazepines, 
while α1-containing GABAARs mediate the sedating properties of these drugs (Atack, 
2010). 
 The growing interest in GlyR α subtype differences has highlighted an important 
gap in GlyR pharmacology.  None of the known GlyR modulators are capable of 
distinguishing between α1-, α2, and α3-containing receptors.  While some modulators 
are more or less potent at a given subtype, none of them are fully specific, limiting their 
use in experimental studies aimed at isolating the contributions of one subtype (Lynch, 
2009).  In an effort to address this lack of subtype-specific modulators, I adapted my 
phage display protocol to identify peptides that show subunit specificity (Tipps et al., 




and α3β receptors in the negative selection process would bias the selection toward 
peptides that show preferential affinity for α1β receptors.  
 As with the previous selection, a diverse pool of peptides was identified.  This 
diversity was somewhat surprising given the stringency of the panning process.  The 
a subunits are >90% identical in the extracellular regions, thus including α2- and α3-
containing receptors in the negative selection significantly reduces the quantity of 
“unique” binding sites in the positive selection.  However, amino acid sequence 
homology does not necessarily translate into identical secondary structures, thus even 
regions that share amino acid sequences between the channel subtypes may offer binding 
sites that are not structurally identical due to differences.  
While the selectivity for α1β over α2β GlyR was highly successful, only a few 
peptides were able to discriminate between α1β and α3β receptors.  At 30 µM, D7.2-128 
significantly enhanced the response of α1β GlyR (t = 6.022, p < 0.005), without 
significantly altering the responses of α2β or α3β GlyRs (α2β: p = 0.046, α3β: p = 
0.392).  However, this specificity did not hold at higher concentrations.  Given the high 
sequence homology of α1- and α3-containing GlyRs, it is not surprising that many 
peptides would display affinity for both subtypes.  During the panning process, phage 
carrying peptides with high affinity for α2β and α3β GlyRs would be largely selected 
out; however, peptides with a low affinity for these channels and a high affinity for α1β 
would likely not be fully removed and would thus be carried on to subsequent rounds.  
Adjustments in the selection process, such as increased rounds of negative selection prior 




There are several possible explanations for the atypical concentration-response 
curves observed.  One possibility is that multiple binding sites with differing affinities 
exist on the GlyR, and thus the observed effects are actually a combination of two distinct 
actions.  This could explain why none of the mutations fully inhibited the peptide effect.  
However, without any indication of where these peptides may be binding, it is difficult to 
address the question of specific binding sites.  It is also possible that aggregation, a 
common complication when dealing with peptides, occurs at higher peptide 
concentrations (Chi et al., 2003).  A reduction in free peptide due to aggregation followed 
by a slow reaccumulation could explain the drop and subsequent reinstatement of the 
peptide effect.  While it is extremely likely that aggregation occurs for a subset of the 
tested peptides, this phenomenon is difficult to measure for small peptides, especially 
when the aggregation occurs at low concentrations.  A third option is the presence of a 
contaminant that also modulates the GlyR.  This possibility will be explored in the 
following chapter. 
In conclusion, while none of the peptides identified in this panning showed 
complete specificity between the three α subtypes, several peptides showed preferential 
modulation of α1β GlyR over α2β and α3β GlyRs.  These peptides are promising leads 
toward the development of more specific compounds.  The effect of D7.2-014 was 
altered by mutating residues within the α1 subunit, suggesting that the differential 






5.0 | TRIFLUOROACETATE MODULATES THE GLYCINE RECEPTOR 
 
5.1 - Introduction 
Trifluoroacetic acid (TFA) is a strong carboxylic acid. In peptide synthesis, it is 
used as an ion-pairing agent in high-performance liquid chromatography (HPLC) 
purification.  The addition of TFA increases the hydrophobicity of molecules by forming 
ionic pairs with their charged groups.  This allows for interactions between the molecules 
and the hydrophobic stationary phase, thus enabling separation (Garcia, 2005).  TFA 
binds to the free NH2 termini of peptides and the side chains of lysine, histidine, and 
arginine residues (Cornish et al., 1999).  The ion pairs formed by TFA are extremely 
strong, and cannot be removed without an additional ion replacement step during 
purification.  As a result, HPLC prepared peptides often exist as trifluroacetate salts.  The 
presence of TFA can alter the behavior of a peptide or modify its conformation (Roux et 
al., 2008).  
In its acetate form, TFA affects several biological processes. The most common 
source of free TFA in the body is the metabolism of the volatile anesthetics halothane, 
isoflurane and desflurane (Cohen, 1971; Hitt et al., 1974).  It has been suggested that 
TFA as a metabolic end product may be responsible for the development of halothane-
induced hepatitis and neurotoxicity (Gut et al., 1995; Ma et al., 1990), as well as playing 
a role in the cardioprotective effects of isofluorane (Han et al., 2001).  In addition, TFA 
alters the proliferation rates of certain cell types, increasing the growth rate of some, 




underlying these effects on cell reproduction are unknown; however, TFA is a chaotropic 
anion, and other compounds of this class can have an impact on membrane function, 
enzymatic catalysis, secondary protein structure, and protein stability. 
All of the peptides investigated in this thesis were tested as TFA salts.  In an 
attempt to address some of the inconsistencies in the peptide modulation of the glycine 
receptor (GlyR), we examined the effects of TFA on GlyR function.  We found that TFA 
is not only able to reversibly modulate glycine responses, but also shows differential 
modulation of receptor subtypes.  This is important both with regard to the testing of 
future peptides and possible secondary effects following the administration and 
metabolism of volatile anesthetics, for which the GlyR is a major target (Harris et al., 
1995).  
 
5.2 - Materials and Methods 
The isolation, injection and two-electrode voltage clamp of Xenopus oocytes were 
conducted as described in Chapter 2.  Specific methods pertaining to the experiments 
presented in this chapter are outlined below.  All chemicals were obtained from Sigma-
Aldrich (St. Louis, MO) unless otherwise noted. 
Two high-resistance (0.5 – 10 MW) glass electrodes filled with 3 M KCl were 
used to impale the animal poles of isolated oocytes injected with  
GlyR cDNA (1:20 a:b).  Cells were voltage-clamped at -70 mV using a Warner 
Instruments OC-725C oocyte clamp (Hamden, CT), and MBS was perfused over them at 




Vernon Hills, IL) through 18-gauge polyethylene tubing.  All peptide and chemical 
solutions were prepared in MBS.  All applications (15 - 30 sec) were followed by 5 – 10 
min washout periods as appropriate.  
 Current peak responses were measured from chart recorder tracings or 
calculated from digital LabChart files.  Peptide effects were calculated as percent changes 
compared with the effects produced by glycine in the absence of peptide. The percent 
enhancement or inhibition values obtained in the presence of peptide were compared by 
either one- or two-way analysis of variance, as indicated, to determine statistical 
significance, with a criterion of p < 0.05. 
 
5.3 - Results 
5.3.1: TFA Modulates α1β  GlyRs 
 Low concentrations of glycine generating a response corresponding to 10% of the 
maximal response (EC10) were applied alone and in the presence of various 
concentrations of TFA (Figure 5.1).  TFA reversibly enhanced the glycine response in a 
concentration-dependent manner.  The potentiating effect began around 0.0005 mM, 
reaching a peak at 0.01 mM.  Preincubation of the oocyte with TFA alone did not alter 
the holding current, suggesting that TFA cannot activate the channel and is not altering 
the function of any of the other endogenous oocyte proteins responsible for the holding 
current.  In addition, TFA did not alter the response elicited by a maximally effective 
concentration of glycine, suggesting that it acts as an allosteric modulator of the GlyR 




effect of TFA alone on the holding currents generated by a range of command voltages (0 
to -70 mV) to rule out non-GlyR effects on the oocyte membrane. None of the 
concentrations tested (0.001 mM – 10mM) had any effect on the holding current at any of 





Figure 5.1 – Trifluoroacetate (TFA) potentiates α1β  GlyR function 
 
EC10 glycine was co-applied with various concentrations of TFA (0.0005 – 10 mM).  A robust 
potentiating effect was seen at 0.001 mM TFA and appeared to plateau by 0.01 mM.  None of the 
concentrations of TFA tested had any effects on holding currents when applied in the absence of 
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Figure 5.2 – TFA allosterically modulates the α1β  GlyR 
 
 Sample tracings of the effect of 100 µM TFA on the response to maximal glycine (10 mM, A) and  
EC10 glycine (B).  For both tracings, TFA was applied alone for 30 s followed by co-application with 
glycine.  TFA did not alter the holding current when applied alone.  TFA significantly enhanced the 




5.3.2: TFA Differentially Modulates GlyR Subtypes 
 As several of the peptides generated with contaminating TFA show subunit-
specific effects on the GlyR, we tested the effect of TFA on homomeric α1 channels, as 
well as heteromeric α2β, and α3β channels.  Concentration response curves for each 
channel subtype are illustrated in Figure 5.3A. GlyR α2β channels were the least 
responsive to TFA, showing no effect below 0.01 mM TFA. Heteromeric α3-containing 
channels also did not respond to lower concentrations of TFA.  For both subtypes, the 
maximal percent change in the EC10 response elicited by the tested TFA concentrations 
was approximately half that seen for α1β receptors.  Interestingly, α1 homomeric 
channels were also less sensitive to modulation by low concentrations of TFA than α1β 
receptors (Figure 5.3B).  However, above 0.1 mM, the effect of TFA on the homomeric 







Figure 5.3 – TFA has differential effects on GlyR α  subtypes 
 
(A) Percent changes in EC10 glycine responses when glycine is co-applied with various concentrations of 
TFA (0.005 – 10 mM) on Gly α1β (black circles), α2β (white circles) and α3β (black triangles) receptors.  
Concentrations of TFA above 0.001 mM robustly potentiated Gly a1b channels.  TFA potentiation of α2β 
and α3β receptors was weaker than for α1β and required a higher concentration of TFA (> 0.01 mM).  
(B) Percent change in EC10 glycine responses when glycine was co-applied with various concentrations of 
TFA (0.0005 – 10 mM) on Gly α1β (black circles) and α1 (white circles) receptors.  TFA robustly 
potentiated both α1β heteromeric and α1 homomeric receptors; however, potentiation of α1 homomeric 




5.3.3: Contribution of TFA to Peptide Effects 
 Once a peptide synthesized as a TFA salt is exposed to a high salt solution, such 
as the MBS perfusion media, TFA dissociates from the peptide.  Thus, any contribution 
of TFA to the peptide responses should be in the form of free TFA, rather than peptide-
bound TFA that directly alters peptide folding or channel interaction.  None of the TFA 
curves generated can directly account for all of the effects seen with the characterized 
peptides.  However, this does not rule out the possibility that the peptide effects reported 
previously are the result of a combination of peptide and TFA actions on the GlyR, 
similar to the interaction noted between ethanol and zinc (McCracken et al., 2010).  To 
conclusively delineate the role of TFA, we obtained a previously tested peptide, D12-116 
synthesized as a chloride salt lacking any TFA contamination.  Figure 5.4 shows the 
comparison between the response to the original peptide (with unknown levels of TFA) 
and the new chloride salt peptides (no TFA).  In the absence of TFA, the peptide still 
robustly (117.29 ± 13.69%) potentiated the glycine response.  While the magnitude of the 
response differed somewhat from that of the original peptide, the difference was not 
significant (p = 0.889), suggesting that the potentiating effect is due to the peptide rather 





Figure 5.4 – Effects of peptide D12-116 on α1 GlyR when applied as a TFA salt or a chloride 
salt 
 
Percent change in EC10 glycine response when glycine was co-applied with 30 µM of D12-116 
purified as either a TFA salt or a chloride salt.  Both forms of peptide D12-116 robustly potentiated 






5.4 - Discussion 
These experiments demonstrate that TFA, a common contaminant in synthesized 
peptides and a major metabolite of halothane, isofluorane and desfluorane, acts as an 
allosteric agent to potentiate GlyR function.  While TFA, due to its highly reactive 
nature, is widely believed to have global, non-specific protein effects, the responses here 
were reversible and did not alter maximal glycine responses, indicative of a transient 
allosteric modulator.  In addition, even high (10 mM) concentrations of TFA alone do not 
affect GlyR function in the absence of glycine nor did they affect any other endogenous 
oocyte membrane protein that contributes to the holding current.  This effect, though 
surprising, is not unheard of.  TFA has also been shown to reversibly enhance ATP-
sensitive potassium (KATP) channels, an effect that is thought to be the basis for the 
cardioprotective effects of isofluorane (Han et al., 2001).  In addition, the GlyR is a well-
known target of the volatile anesthetics from which TFA is metabolized in vivo (Mascia 
et al., 1996a; Mihic et al., 1997; Zhang et al., 2003).  The modulation of GlyR by TFA 
opens up several lines of inquiry. First, is this effect limited to the GlyR, or are other 
anesthetic targets also modulated by this compound?  Other Cys-loop family channels in 
particular should be examined for their sensitivities to TFA.   Secondly, is the binding 
site for TFA distinct from the binding site of the volatile anesthetics from which it is 
metabolized?  A large body of research exists regarding the location of the binding site 
for these anesthetic compounds (Mihic et al., 1997; Roberts et al., 2006).  It would be of 




Recently, TFA has received much attention as the primary breakdown product of 
hydrochlorofluorocarbons (HCFC) and hydrofluorocarbons (HFC), compounds that were 
developed as alternatives to the ozone-depleting chlorofluorocarbons (Franklin, 1993).  
Because HFC and HCFC compounds return to earth rather than lingering in the 
atmosphere, their breakdown products could have significant effects on several 
environmental systems (Likens et al., 1997).  TFA has been of special interest due to 
several reports that it may be toxic to different kinds of algae and bacteria, leading to 
concern regarding the long-term implications of TFA accumulation (Likens et al., 1997).  
Thus the effect of TFA may quickly become an important area of study as the 
environmental levels increase. 
TFA exhibits unusual differences among the various subtypes of GlyR channels. 
Of particular interest to the peptide work discussed in the previous chapters, TFA 
modulates both α1 and α1β receptors, but with differing sensitivities.  Both receptor 
types were potentiated by TFA, but α1 homomeric receptors require much higher TFA 
concentrations before the effect is seen.  This may explain why the peptides tested against 
homomeric channels exhibited normal concentration-response curves even in the 
presence of contaminating TFA.  For peptides tested against α1 receptors, contaminating 
concentrations of TFA above 0.01 mM would be required to see any significant effect. 
However, for peptides tested against the more sensitive α1β receptors, much lower 
concentrations of TFA could conceivably alter channel function or the channel:peptide 
interaction.  With that in mind, it is important to note that TFA contamination alone 




the tested concentrations of TFA inhibited GlyR responses, while several of the peptides 
did.  While this does not conclusively rule out the possibility of a combination of TFA 
and peptide effects on these channels, it does strongly suggest that at least part of the 
modulatory effects seen were due to the peptides themselves. 
With regard to future experiments using peptide modulators, the best approach is 
to synthesize the peptides without the contaminating TFA. Several ion-replacement 
methods have been shown to successfully remove TFA, leaving the peptide as either and 
acetate or a chloride salt (Roux et al., 2008). This approach would circumvent the 
concerns that TFA contamination presents and give a more accurate prediction of the 





6.0 | CONCLUSIONS AND DISCUSSION 
 
6.1 – Overview 
 The CNS is a complex network of interconnected systems, each contributing to a 
multitude of behaviors and disease states.  One method for identifying the contributions 
of individual systems to a given phenotype is the use of highly specific modulators.  The 
research in this dissertation presents a novel approach for using phage display to identify 
peptide modulators of the GlyR, a CNS target with thus far limited options with regards 
to its modulation. The overall conclusion from these studies is that phage display can be 
used to identify peptides that bind to the GlyR and modulate channel function.  This 
approach can be modified to identify peptides that bind with highly specificity by 
enhancing the stringency of the phage selection process.  In addition, our studies indicate 
that TFA, a common contaminant in peptide synthesis and a metabolite of several volatile 
anesthetics, also modulates these channels, emphasizing the need to remove 
contaminating molecules from tested peptides. 
 
6.2 – Identification of Peptide Modulators of the GlyR 
Compared to the other members of the Cys-loop receptor family, the GlyR has a 
very limited pharmacological profile. With the exception of strychnine, every known 
GlyR modulator also interacts with other neuronal targets.  Even the primary ligand, 




specific modulators has slowed investigations into the role of GlyR in disease states and 
various drug-induced behaviors.  In an attempt to address the lack of GlyR modulators, I 
modified traditional phage display techniques in order to identify peptides that bind to 
and modulate the GlyR.  In this dissertation, several promising lead peptides were 
identified and a technique for isolating peptides that differentiate between closely related 
channel targets was developed.  
 The isolation of phage-expressed peptides that bind to transmembrane targets, 
such as ion channels, is complicated by the requirement of a membrane for functional 
folding. The addition of a cellular membrane contaminates the selection process with 
non-specific surface proteins, resulting in increased background binding and the isolation 
of peptides that do not show affinity for the desired target. Methods for overcoming this 
obstacle have been developed, including specific elution using a known ligand 
(Meulemans et al., 1994) and biased phage libraries based on a known ligand for the 
desired target (Hennecke et al., 1997).  However, these approaches limit the area of the 
expressed target that can be investigated.  Subtractive approaches have been used in 
which the phage are presented with cells expressing the target of interest mixed with cells 
without the target, followed by a cell sorting step to isolate the phage bound to the target-
expressing cells (Siegel et al., 1997).  I chose to approach this problem by separating the 
target-expressing and target free cells into two selection steps. This eliminates the need 
for a cell sorting step and ensures that the same background surface is presented in every 




 Whole-cell panning makes it possible to select for ligands that bind to previously 
uncharacterized binding sites and cell surface structures (Lekkerkerker and Logtenberg, 
1999).  Given the high number of isolated peptides and the wide range of modulatory 
effects seen in our D12 panning (Figure 3.1), it is highly likely that some of the 
identified peptides bind to novel modulation sights on the GlyR.  For example, D12-116 
does not compete with glycine at the binding site (Figure 3.4), and when co-applied with 
ethanol, the modulatory effects were additive, suggesting that this peptide also does not 
bind in or over the alcohol binding site. Thus, the information obtained from these 
peptides can also be used to locate new biding sites for which organic modulators could 
conceivably be designed.  
 Although peptides with low nanomolar affinity have been identified directly from 
large libraries, the typical affinity of a linear peptide from a combinatorial library is in the 
high nanomolar to low micromolar range, similar to the peptides identified here (Hartley, 
2002).  Typically, the original selection is used to identify consensus sequences shared by 
several of the isolated sequences.  A second library is generated using this consensus 
sequence and randomized flanking sequences (Szardenings et al., 1997).  The sequences 
identified in our phage pannings were highly diverse, and no clear consensus sequence 
was identified (Tables 1 and 2).  However, the alanine scan of D12-116 highlighted 
residues that are important for its modulatory effects (Figure 3.5).  It would be 
interesting to build a phage library based on the sequence of D12-116 in which positions 




modified versions of D12-116 with a higher affinity for the GlyR than the original 
peptide.      
 
6.3 - Peptides 
While phage display has been successfully used for many years in antibody and 
cancer research, the field of neurobiology has been slow to embrace this technique. In 
part, this is due to reservations regarding the end product: peptides.  As experimental 
agents, peptides are relatively cheap to manufacture, and can be stored for long periods of 
time in their lyophilized form.  Therapeutically, peptides are less ideal. As a general rule, 
peptides do not cross the blood-brain barrier (BBB), making them difficult to administer 
for CNS-related purposes.  However, because they represent the smallest functional part 
of a protein, peptides have better efficacy, selectivity, and specificity than small organic 
molecules (Hummel et al., 2006).  In addition, peptides break down into amino acids and, 
due to their short half-life, do not accumulate in tissues, resulting in negligible toxicity 
(Loffet, 2002). Thus, if proper delivery techniques were developed, peptides would make 
excellent CNS modulators.  To this end, several promising CNS delivery methods are 
being investigated.  Endogenous BBB transporter systems can be utilized to carry drugs 
into the brain (Tamai and Tsuji, 2000).  In addition, certain peptide sequences, referred to 
as cell penetrating peptides (CPP), have also been shown to cross membrane barriers with 
no additional assistance, raising the possibility that some careful modifications could 
carry almost any peptide across the BBB without the need for a secondary carrier 




peptides to brain tissue (Morris et al., 2008).  For example, the TAT peptide, an 11 amino 
acid peptide isolated from the coat of the HIV virus, has been used to carry biologically 
active proteins across the BBB (Cai et al., 2011; Rapoport and Lorberboum-Galski, 
2009).  Nanoparticles have also been highly successful in delivering systemically 
administered peptides into brain tissue at pharmacologically relevant concentrations 
(Karatas et al., 2009).  Efforts to improve the oral delivery of peptides in order to increase 
their marketability as therapeutic agents are also underway (Hamman et al., 2005). 
 
6.4 – The Utility of GlyR Modulation 
In addition to the experimental uses for GlyR modulators, several potential 
therapeutic applications exist.  In the spinal chord, GlyRs mediate reciprocal inhibition in 
stretch reflex circuits via interneurons and the recurrent inhibition of motoneurons via 
Renshaw Cells.  Thus, a reduction in GlyR-mediated conductance leads to changes in 
muscle tone (Floeter and Hallett, 1993), most notably hyperekplexia and spasticity.  
Spinal a3 GlyRs play an important role in inflammatory pain responses (Harvey et al., 
2004), and molecules that can enhance the activity of these GlyRs would be promising 
candidates as anti-inflammatory analgesic compounds.  Changes in the expression levels 
of hippocampal GlyRs have been reported in patients with temporal lobe epilepsy 
(Eichler et al., 2008) and in sensory processing systems, GlyRs play a role in the 
modulation of circuits in the central auditory pathway and the receptive fields of the 





6.5 – Future Directions 
The peptides identified in this dissertation have the potential to serve as excellent 
leads for identifying high affinity GlyR modulators. As discussed above, the development 
of libraries based on the peptides identified here and mutagenesis studies comparing 
receptor subtypes may lead to improved peptide modulation and the identification of 
channel residues that are critical for these effects.  However, the ultimate utility in the 
peptides identified here lies in evaluating their effects on GlyR-related behaviors.  For 
example, intracranial delivery of D12-116 into the NAcc would be expected to decrease 
ethanol consumption, based on data from the Söderpalm group (Molander et al., 2005; 
Molander et al., 2007).  
An important aspect of the selection process developed to identify GlyR-binding 
peptides is how easily it can be adapted for other targets.  In our lab, this panning 
technique has been used to identify peptides that show affinity for GABAA receptors.  In 
addition, other labs have adapted the selection protocol to identify peptides that act as 
antagonists at the SK channel, and we are currently collaborating to expand this work to 
target the BK channel, another well-known target of alcohol actions (Treistman and 
Martin, 2009).  
Future applications of this method may be improved by the utilization of 
phagemid libraries.  Phagemid libraries have the advantage of being monovalent display 
systems, that is, only one copy of pIII carries the fused peptide.  When using naïve 
libraries, polyvalent display and a high concentration of target will increase the chances 




applied using these selection conditions, I chose to start with a more conservative 
selection process.  While the choice of a polyvalent system did yield a diverse pool of 
peptides with the ability to modulate the GlyR, most had a low potency.  This could 
reflect a bias toward low affinity binding in our assay.  It could also be an effect of 
avidity.  Avidity refers to the vast increase in overall affinity that results from the 
summation of two or more monovalent interactions that are individually weak.  The five 
peptide copies that exist on each phage are in close proximity, a very different situation 
from the application of low concentrations of free peptide.  The use of a monovalent 
display system will bias selection toward high affinity binders and may result in the 
isolation of peptides with a much higher potency at the GlyR.  This approach may also 
help resolve the lack of specificity seen in the more stringent selection for subunit 
specific GlyR modulators. 
In summery, the research presented in this thesis describes a high throughput 
method for identifying novel allosteric modulators of channel function.  The application 
of this technique to the GlyR resulted in several highly promising lead peptides, opening 
new avenues for the discovery of GlyR-specific modulators and the opportunity to 
identify novel modulatory sites on the GlyR.  The ease with which this method can be 
adapted to other channel systems highlights the utility of phage display selection in the 
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